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It is commonly accepted that general anesthesia produces unconsciousness and amnesia.  
However, the extent to which the anesthetized brain receives and retains information is not well 
understood.  Memory of a given event relies upon initial consolidation and subsequent retrieval.  
In order to test the effects of anesthesia on these separate memory components, we compared 
what rats reported behaviorally with what their brains ‘reported’ histologically.   
In chapter 2, we fully anesthetized rats with ketamine/xylazine anesthesia and exposed 
the animals to a novel odorant mixture.  The following day the rats were presented with the same 
odorant mixture while awake in order to assess behavioral familiarity.  The rats demonstrated no 
memory of the odorants previously presented during anesthesia.  In order to assess odor-induced 
brain changes, rats were sacrificed for histological analysis 2 hours after exposure to the odorants 
during anesthesia, or 2 hours after re-exposure while awake the following day.  We quantified 
the protein expression of c-fos, an immediate early gene thought to be critical for memory 
consolidation, in cortical olfactory regions.  During anesthesia, a novel odorant mixture activated 
c-Fos similar to that found in awake animals.  Repeated exposure to the odorants caused an 
attenuation of c-Fos regardless of whether the initial exposure occurred while anesthetized or 
awake.  This suggests that memory-related protein changes can occur in olfactory cortical 
regions despite anesthesia.   
 iv 
Given, the potential information consolidation observed in these ketamine/xylazine 
anesthetized animals, we attempted to retrieve olfactory memories using additional behavioral 
paradigms and memory-enhancing drugs in chapter 3, but were unable to reveal any explicit 
memory formation.  However, we found subtle changes in odorant approach latency, suggesting 
a potential implicit memory.  Further histological investigation in chapter 4 revealed that changes 
in odor-induced neurogenesis could also occur despite ketamine/xylazine anesthesia, similar to 
that found with c-Fos labeling, thus supporting the permissive role of this anesthetic.  However, 
odor-related changes in c-Fos did not occur with the anesthetics pentobarbital or propofol, 
suggesting these traits are not universal amongst all anesthetics.  Nevertheless, these data 
indicate a functional disconnection between the cortical representation of an environmental 
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1.0  GENERAL INTRODUCTION 
The only proof of there being retention is that recall actually takes place. 
 –William James (1890) 
 
There may exist a discrepancy between what we know and what our brain ‘knows’.  That is, our 
conscious perception may belie the full extent of information that is actually stored in our brains.  
One striking example of this comes from the blindsight literature.  In the mid-1970s it was 
discovered that individuals, who were perceptually blind due to damage to primary visual cortex, 
appeared to retain some visual capacity (Weiskrantz et al., 1974).  When prompted to guess, 
blindsight patients are able to strikingly discriminate object orientation, movement and 
wavelength information though they deny seeing anything (Weiskrantz, 1996; Cowey, 2010).  
These findings have been shown to extend to individuals with whole cerebral hemispherectomy 
(Ptito and Leh, 2007), in monkeys with lesions to the primary visual cortex (Cowey and Stoerig, 
1995; Stoerig and Cowey, 1997) and even across auditory (Garde and Cowey, 2000) and tactile 
modalities (Paillard et al., 1983).  In the case of blindsight, it is thought that this sub-conscious 
information may reside in auxiliary visual regions (Leh et al., 2006; Ptito and Leh, 2007).  While 
the exact neuronal correlates of blindsight remain unclear, these studies elucidate a discrepancy 
between what information is perceived and what information is integrated into the brain.   
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Many parallels exist between blindsight and the anesthetized brain state.  In the 
anesthetized brain, disrupted sensory processing produces unconsciousness and amnesia of 
perianesthetic events (Franks, 2008); however, a fair degree of sensory signaling still occurs.  
Brain imaging and electrophysiological studies have revealed that information can still be 
transmitted during general anesthesia, and that some information is even received by higher 
cortical areas where perception is thought to occur (Haberly, 1969; Nemitz and Goldberg, 1983; 
Onoda et al., 1984; Bonhomme et al., 2001; Veselis et al., 2005; Rinberg et al., 2006).  Both 
blindsight and anesthesia produce a lapse in perception and involve a mix of preserved and 
disrupted brain functions.  Similar to that found in blindsight, it is possible that in the 
anesthetized brain some level of information may still be registered, and perhaps is even 
accessible.  The potential and extent of information integration during anesthesia and 
information retrieval following anesthesia are the foci of this dissertation.   
1.1 MEMORY AND ANESTHESIA 
The extent to which anesthesia affects memory acquisition versus memory retrieval is not well 
understood.  Memory recall is known to be impaired following general anesthesia; however, as 
William James pointed out over a century ago, failure to recall a memory does not prove that the 
memory trace does not exist (James, 1890).  Since that time, numerous studies investigating the 
causes of memory failure have revealed much about the nature of memory.  In the 1940’s, a 
series of studies showed that amnesia could be induced when electroconvulsive shock (ECS) was 
applied following complex maze learning in the rat.  The severity of the deficit increased the 
sooner the ECS treatment followed learning (Duncan, 1945, 1948, 1949).  It was thought that 
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this window of efficacy suggested a period of memory lability, termed memory consolidation, 
where new memories are susceptible to factors that enhance, inhibit or alter the memory trace 
before it becomes stable (Glickman, 1961; Sara, 2000; Sara and Hars, 2006).  Aside from ECS, a 
number of agents, when administered during this period, produce experimentally-induced 
amnesia including: protein synthesis inhibitors, ethanol, hypoxia, hypothermia and antagonists of 
N-Methyl-D-aspartic acid (NMDA) receptors, β-adrenergic receptors, polysialylated neural cell 
adhesion molecule (PSA-NCAM) and cholinergic function (Hayes, 1953; Potts and Bitterman, 
1967; Jensen et al., 1975; Rose, 1995b; Przybyslawski et al., 1999; Tronel and Sara, 2003; 
Carballo-Marquez et al., 2007; Spinetta et al., 2008).  Experimentally induced amnesia can also 
be produced by general anesthesia administered during the period of consolidation (O'Gorman et 
al., 1998; Alkire and Gorski, 2004; Imre et al., 2006).  Thus it is possible that anesthesia-induced 
amnesia results from a disruption of initial information consolidation processes. 
However, others have challenged the idea that memory failure results from an 
interruption in normal consolidation (Lewis and Maher, 1965; Miller and Springer, 1973).  
Experimentally induced amnesias were shown to spontaneously reverse or decay over time in 
some cases (Zinkin and Miller, 1967; Kohlenberg and Trabasso, 1968; Sara and Hars, 2006), 
whereas in others, re-exposure to the training environment or a learning cue could reverse 
amnesia and facilitate memory retrieval (Quartermain et al., 1972; Devietti and Hopfer, 1974).  
Alternatively, amnesias, including anesthesia-induced amnesia, could be reversed by nootropic 
(cognitive-enhancing) or psychostimulant drugs, thus restoring the memory trace (Quartermain 
and Leo, 1988; Pang et al., 1993; O'Gorman et al., 1998).  The resurfacing of amnestic memories 
indicates that the memory trace must have been stored initially.  This would suggest that 
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anesthesia-induced memory failure results from a deficit in retrieval, and not consolidation, 
processes.   
However in these cases, anesthesia-induced amnesia was produced by fully anesthetic 
doses immediately after learning, or sub-anesthetic doses during learning.  In both cases the 
animal was mostly lucid for the training event.  For associations occurring at clinically relevant 
doses, where the individual is unresponsive to the environment, a disruption of initial 
consolidation may be more likely.  Today, it is typically thought that surgical doses of general 
anesthetics act to block information integration into the brain (Alkire et al., 2008).  The 
disruption of initial consolidation may seem intuitive; however, currently there is little direct 




Figure 1-1.  Psychological and physiological effects of a typical anesthetic at increasing dose 




What is known about general anesthesia and memory is that these anesthetics can 
produce robust amnesia of perianesthetic events.  General anesthetics produce anterograde 
amnesia in a dose-dependent manner (Pang et al., 1993; Alkire and Gorski, 2004) and can 
produce retrograde amnesia at higher doses (O'Gorman et al., 1998).  The relative potency of 
various anesthetics in producing amnesia has been shown to mirror their lipid solubility (Alkire 
and Gorski, 2004).  Memory impairment is thought to occur at lower anesthetic doses (Fig. 1-1) 
than loss of consciousness (Antognini and Carstens, 2002).  Some have suggested that memory is 
impaired long before consciousness (Alkire et al., 2008).  The amnesia produced by anesthetics 
is typically described in the context of explicit memory.  Explicit memory is the conscious 
recollection of events, facts and people, and is profoundly impaired by general anesthesia 
(Schwender et al., 1994; Chortkoff et al., 1995; Munte et al., 2000).  Interestingly, implicit 
memory, i.e. the unconscious memory behind riding a bike or priming effects, may still remain 
intact (Ghoneim et al., 1999; Lubke et al., 1999; Iselin-Chaves et al., 2005); however, others 
have refuted this claim (Rich et al., 1999; Munte et al., 2000; Kerssens et al., 2005). 
1.2 MECHANISMS OF GENERAL ANESTHESIA 
Based on administration route, general anesthetics are divided into intravenous and inhalational 
anesthetics.  Intravenous anesthetics, such as propofol or ketamine, are typically used for the 
rapid induction of anesthesia, whereas inhalational anesthetics, such as sevoflurane or nitrous 
oxide, are often used to maintain the anesthetic state.  However, these roles are not absolute.  
There is tremendous diversity in the molecular structure of various anesthetics ranging from 
single atoms and simple molecules to much larger halogenated ethers, barbiturates and 
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benzodiazepines.  Despite the similar phenotypes produced by these various agents, their 
structural diversity has proved challenging for scientists to come up with a unifying theory of 
anesthetic action. 
At the molecular level, considerable research has been done regarding the mechanisms of 
general anesthetics.  At the turn of the twentieth century, Hans Horst Meyer and Charles Ernest 
Overton independently proposed that the fatty membrane components of neurons were the 
common targets of general anesthetics based on a strong correlation between anesthetic potency 
and anesthetic solubility in olive oil (Meyer, 1899; Overton, 1901).  However, it has since been 
found that various anesthetics can inactivate the soluble protein firefly luciferase in a clinically 
relevant dose-dependent manner (Ueda, 1965; Ueda et al., 1976), suggesting that anesthetics 
could exert their effects directly on proteins.  Challenges to the lipid theory have also come from 
a discrepancy in observed and expected effects with ‘non-immobilizers’ (Kandel et al., 1996; 
Perouansky, 2008) and temperature-based effects on lipids (Franks and Lieb, 1982).  However, 
other findings continue to support a lipid hypothesis, such as the observed cut-off effects with 
long-chain alcohols (Pringle et al., 1981; Raines et al., 1993).  Recently, the ligand-gated ion 
channel has received a lot of attention as a major site of anesthetic action (Franks and Lieb, 
1978; Krasowski and Harrison, 1999).  It is thought that the binding of anesthetics causes 
conformational changes to these integral membrane proteins and may alter the channel dynamics 
(Tang and Xu, 2002; Cui et al., 2008).  Today, the exact molecular mechanisms of general 
anesthesia are not fully understood; however, we do know that anesthetics typically act to 
potentiate the function of inhibitory ion channels and/or suppress the function of excitatory 
channels (Krasowski and Harrison, 1999; Rudolph and Antkowiak, 2004), thus hyperpolarizing 
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the cells and altering excitability.  The relative importance of specific receptor types in mediating 
anesthetic effects is an area of continuing research. 
At the systems level, anesthetics typically do not produce a uniform and global reduction 
of brain activity.  Some anesthetics can even activate the brain (Reinstrup et al., 1994; Duncan et 
al., 1998; Langsjo et al., 2005).  As a result, it has been proposed that general anesthetics act by 
preferentially affecting critical regions of the central nervous system (Eger et al., 1997).  For 
example, propofol is proposed to produce sedation through effects at frontal and other cortical 
regions, hypnotic effects (unconsciousness) through the thalamus and midbrain reticular 
formation and immobility at the level of the spinal cord (Fiset et al., 1999; Alkire et al., 2000; 
Bonhomme et al., 2001; Rudolph and Antkowiak, 2004; Fiset et al., 2005); however, direct 
evidence is lacking and considerable variability exists in the brain regions affected by different 
anesthetics (Veselis et al., 2004).   
It may be possible for anesthetics to affect common signaling pathways despite differing 
molecular targets.  One possible pathway is the thalamus as this region is uniquely positioned to 
gate sensory information to the cortex.  Disrupted thalamo-cortical signaling has been implicated 
in the supraspinal mechanisms of general anesthetics (Alkire et al., 2000; Fiset et al., 2005) 
including those anesthetics that increase global activity (Reich and Silvay, 1989; Alkire and 
Miller, 2005).  Imaging studies utilizing various anesthetics have shown marked changes in 
thalamic activity during the transition to the unconscious state similar to that seen when entering 
deep natural sleep (Bonhomme et al., 2001; Franks, 2008).  Similarly, pharmacological 
inactivation of the thalamus with γ-aminobutyric acid (GABA) agonists can rapidly induce sleep 
in awake rodents (Miller and Ferrendelli, 1990), whereas intrathalamic injection of nicotine can 
cause rats to awaken from anesthesia (Alkire et al., 2007).  Thus, it is possible that the thalamus 
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may act as a switch that allows or prevents coherent sensory information from reaching the 
cortex (Alkire et al., 2000).  However, ablation of the thalamus does not prevent cortical 
activation (Villablanca and Salinas-Zeballos, 1972), suggesting that other regions must also play 
a role in anesthetic effects.  
Brain stem nuclei involved in sleep and arousal have been implicated in anesthetic-
induced unconsciousness (Moruzzi and Magoun, 1949; Franks, 2008).  These critical midbrain 
regions have been shown to be suppressed by volatile anesthetics in a dose dependent manner 
(Ogawa et al., 1992; Keifer et al., 1996).  Various cortical areas, such as mesial parietal and 
posterior cingulate cortices, are also purported to be important (Alkire et al., 2008).  Despite 
much research, a putative locus of anesthetic action in the brain has not been established and thus 
a distributed effect may be most likely. 
Electroencephalogram (EEG) patterns in the human reveal that general anesthetics 
initially produce a paradoxical excitation characterized by fast, low-amplitude alpha and beta 
waves typical of waking states (Gugino et al., 2001).  As the patient approaches 
unconsciousness, these give way to slow, high-amplitude delta waves, characteristic of slow-
wave sleep, which are thought to be produced by thalamocortical neurons (Alkire et al., 2000).  
Deep anesthesia produces a stereotypical burst suppression state, with higher doses eventually 
producing an isoelectric or flat-line EEG, characteristic of brain death (Clark and Rosner, 1973; 
Alkire, 1998; Brown et al., 2010).  This EEG profile is fairly well conserved across anesthetics, 
but there are exceptions (Maksimow et al., 2006).  Anesthetics also disrupt gamma band 
coherence, which is thought to represent the neural synchrony between regions (John and 
Prichep, 2005).  Loss of inter-region connectivity as a mediator of unconsciousness is also 
supported by the sleep literature.  Giulio Tononi demonstrated that transcranial magnetic 
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stimulation (TMS) in the cortex produced a cascade of activity that spread throughout connected 
cortical areas in awake patients.  When these patients were again stimulated during slow-wave 
sleep, the stimulation produced a robust local response; however, there was no spread of activity 
(Massimini et al., 2005). 
In animals anesthetized with steady-state urethane, the EEG state can vary between fast 
and slow-wave states in the absence of external stimuli (Angel, 1991).  In the olfactory system, 
electrophysiological recordings reveal that olfactory areas are more responsive to odorants when 
the anesthetized rodent is in the fast-wave, relative to the slow-wave, EEG state (Murakami et 
al., 2005; Tsuno et al., 2008).  In related work, delivery of a memory cue during fast-wave rapid 
eye movement (REM) sleep was shown to facilitate memory performance, whereas delivery of 
the cue during slow-wave sleep did not (Hars et al., 1985; Hars and Hennevin, 1987).  Clinically, 
EEG has been shown to have difficulty accurately predicting consciousness; however, the 
presence of slow-wave EEG appears to correlate well with robust amnesia of explicit memory 
(Voss and Sleigh, 2007). 
It was found that ‘non-immobilizers’, i.e. drugs that fail to produce immobility despite 
predicted anesthetic qualities, prevented learning and memory without producing complete 
anesthesia, suggesting that the amnestic effects of anesthesia are mechanistically distinct from 
other anesthesia endpoints (Kandel et al., 1996; Perouansky, 2008).  Some think that anesthetic-
induced amnesia may not necessarily be produced through deficits in putative areas of memory 
storage (i.e. hippocampus/medial temporal lobe), but may be produced through effects on 
distributed cortical areas.  In a positron emission tomography (PET) study, propofol-induced 
amnesia was shown to peak at doses that caused reduced cerebral blood flow in working memory 
regions, specifically prefrontal and posterior parietal regions (Veselis et al., 2002).  However, 
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virtually all anesthetics have also been shown to have an effect at the hippocampus as well 
(Wakasugi et al., 1999), and this region has been suggested to play a large role in the amnestic 
effects of anesthesia (Grimm et al., 1997; Ren et al., 2008; Perouansky and Pearce, 2011).  
Reduced arousal from brainstem regions could also contribute to anesthetic-induced amnesia 
(Yasoshima et al., 2006; Shea et al., 2008).   
Interestingly, although higher-order cortical areas are thought to be disrupted by 
anesthesia, primary sensory regions of the cortex appear to retain normal activity during the 
presentation of sensory stimuli (Rudolph and Antkowiak, 2004; Alkire et al., 2008).  Similarly, 
in vegetative patients environmental stimuli are able to elicit robust brain activity in primary 
sensory cortices, but not in higher-order regions (Laureys et al., 2002). 
1.3 IMMEDIATE-EARLY GENES AND MEMORY 
As James (1890) indicated, the fundamental flaw in memory research is that memory acquisition 
is often inferred based on behavioral recall.  If the information was stored, but is unable to be 
retrieved, analysis of recall alone would obscure this fact.  Teasing apart consolidation and recall 
is a challenge, but is becoming more accessible as imaging techniques and other technologies 
improve.  It is generally believed that initial memory formation results from changes in synaptic 
efficacy which is strengthened by the synthesis of new proteins.  Other competing hypotheses 
exist; however, most indicate that de novo protein synthesis is involved (Alkire and Guzowski, 
2008; Hernandez and Abel, 2008; Miyashita et al., 2008).  The importance of protein synthesis in 
memory formation was implicated early on as a number of studies demonstrated that intracranial 
injection of protein synthesis inhibitors prevented long-term, but not short term memory 
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formation (Flexner et al., 1963; Agranoff et al., 1965; Potts and Bitterman, 1967).  The 
involvement of new protein synthesis in memory formation suggests that it may be possible to 
visualize the mechanisms of consolidation through monitoring changes in protein expression.   
 Immediate-early genes (IEGs) are a class of genes that are rapidly and transiently induced 
by a variety of stimuli without the need for prior protein expression (Guzowski, 2002).  These 
genes constitute the first wave of transcription in response to a stimulus.  In short, patterned 
synaptic activity increases the intracellular Ca2+ content, which activates a series of protein 
kinases.  These kinases, in turn, activate specific transcription factors which induce robust IEG 
transcription within minutes of the initial stimulation (Greenberg et al., 1986; Guzowski, 2002).  
Though IEGs can be expressed in the presence of protein synthesis inhibitors, these genes can 
influence the expression of a large number of proteins (Terleph and Tremere, 2006), thus they 
are well positioned to mediate the amnestic effects of protein synthesis inhibitors described 
above.  Some IEGs encode “effector” proteins that directly influence neural function; however, 
the majority of IEGs encode regulatory transcription factors which impact a broad array of 
targets described as late-response genes (Herdegen and Leah, 1998; Lanahan and Worley, 1998; 
Tischmeyer and Grimm, 1999).  The exact mechanisms by which these activated transcription 
factors enhance synaptic efficacy and promote consolidation are not well understood.  However, 
in one example, it has been shown that IEGs, such as c-Fos, can activate matrix 
metalloproteinases (MMPs) which enzymatically act at synaptic structural proteins to induce 
neural remodeling (Kaczmarek et al., 2002). 
Over 40 immediate early genes have been discovered including c-fos, egr-1 (i.e. zif268 or 
krox-24), c-jun and arc.  The IEG, c-fos, and its gene product, c-Fos, belong to the leucine-zipper 
family of transcription factors which includes Fra-1, Fra-2 and FosB (Terleph and Tremere, 
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2006).  Knockdown or knockout of c-Fos impairs long-term memory, but not short-term memory 
(Paylor et al., 1994; Mileusnic et al., 1996; Grimm et al., 1997; Fleischmann et al., 2003; 
Yasoshima et al., 2006), a similar pattern to that seen with protein synthesis inhibitors suggesting 
that c-Fos may be functionally related to protein-dependent memory processes.  Knockdown of 
the related IEG, Arc, produces a similar memory impairment (Guzowski et al., 2000; McIntyre et 
al., 2005).  IEG knockdown prior to the training phase impairs memory, however knockdown 
prior to the behavioral test has no effect (Lamprecht and Dudai, 1996), indicating that IEGs are 
involved in memory storage but not retrieval.  In general, immediate early genes are elicited by 
patterns of neural activity that produce long lasting changes in synaptic efficacy, i.e. long-term 
potentiation (LTP) (Abraham et al., 1991; Kaczmarek, 1992; Abraham et al., 1993; Worley et al., 
1993), and disruption of IEGs can impair the maintenance of LTP (Guzowski et al., 2000; 
Fleischmann et al., 2003).  Several researchers have proposed that immediate early genes are 
critically involved in the mechanisms of memory consolidation (Kaczmarek, 1993; Tischmeyer 
and Grimm, 1999; Guzowski, 2002; Alkire and Guzowski, 2008).  This does not imply that 
immediate early gene expression indicates the presence or absence of a memory trace, but as 
John Guzowski’s group describes (in relation to the immediate early gene, arc): “…Arc is 
merely one element in a network of genes that interact in a coordinated fashion to serve memory 
consolidaton (Miyashita et al., 2008).” 
1.4 ORGANIZATION OF THE OLFACTORY SYSTEM 
Olfactory information from the environment is detected by olfactory sensory neurons (OSNs) 
within the olfactory epithelium.  The OSNs send information from the epithelium to spherical 
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dendritic clusters in the main olfactory bulb called glomeruli (Scott et al., 1993).  When a 
particular odorant binds to the olfactory epithelium it activates a discrete set of OSNs expressing 
the same olfactory receptor, which in turn activates a unique spatial pattern of glomeruli 
described as an ‘odor map’ (Uchida et al., 2000; Korsching, 2002; Xu et al., 2003).  Different 
odors each produce a characteristic odor map in the olfactory bulb.  The main olfactory bulb is 
the initial stage of odor processing in the brain (Fig. 1-2) and is composed of three main cellular 
layers: the glomerular, mitral and granule cell layers.  The glomerular and granule cell layers 
compose the superficial and deepest layers of the bulb, respectively, and contain interneurons 
that are thought to enhance odor discrimination and sensitivity (Mori et al., 1999; Lledo and 
Lagier, 2006; Giridhar et al., 2011).  The mitral cell layer contains mitral and tufted cells which 
are the excitatory projection neurons that relay information to downstream targets.  The olfactory 
bulb also receives significant centrifugal inputs, from various brain regions, thought to modify 
odor arousal and processing (Mouret et al., 2009). 
 
Figure 1-2.  Schematic of information flow in the olfactory system 
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 The projection neurons of the olfactory bulb send information via the olfactory tract to 
the piriform cortex, the largest of the cortical olfactory areas, and other regions including the 
anterior olfactory nucleus, amygdala and entorhinal cortex (Shepherd, 2007).  The piriform 
cortex is a phylogenetically old, three-layered archicortex and is a critical secondary region of 
olfactory processing (Fig. 1-2).  The odor maps produced in the olfactory bulb are not preserved 
in the piriform cortex, instead projections from each glomerulus are distributed widely 
throughout the piriform cortex creating distributed clusters in the anterior piriform cortex (APC) 
and dispersed connections in the posterior piriform cortex (Luskin and Price, 1982; Haberly, 
1985, 2001).  Anterior and posterior piriform cortices display unique electrophysiological 
properties (Jung et al., 1990; Litaudon et al., 1997).  The neurons of the anterior piriform cortex 
show greater c-Fos immunoreactivity in response to olfactory stimulation than those of the 
posterior piriform cortex (Datiche et al., 2001; Roullet et al., 2004).  The APC also receives the 
greatest amount of input directly from the olfactory bulb and is the primary relay to higher 
cortical regions (Haberly and Bower, 1989; Illig, 2005), thus we chose to focus on this region of 
the piriform cortex.   
This secondary region of olfactory processing (Fig. 1-2) displays odor receptive fields 
similar to that found in the olfactory bulb; however, these APC neurons show greater odor 
specificity (Wilson, 2000a, b) and also exhibit a rapid odor habituation despite sustained bulbar 
activity (Wilson, 1998).  Electrophysiological studies demonstrate that the APC is a mix of 
associative (responding when odor is paired with reward) and purely sensory neurons 
(Schoenbaum and Eichenbaum, 1995; Roesch et al., 2007).  However, c-Fos immunolabeling in 
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the APC suggests that these neurons appear to be similarly activated by sensory and associative 
stimuli (Datiche et al., 2001; Tronel and Sara, 2002; Roullet et al., 2005a). 
The APC has been found to be essential for the discrimination of odors (Staubli et al., 
1987b; Wilson, 2001; Wilson and Stevenson, 2003) and is thought to be involved in olfactory 
learning and memory (Barkai and Saar, 2001; Sanchez-Andrade et al., 2005), but not recall 
(Roullet et al., 2004).  Lesions to the piriform cortex significantly impair the ability of rats to 
acquire new odor discriminations.  Effects are greatest for the acquisition of complex odorant 
combinations relative to simple odorants (Staubli et al., 1987a).  In one study, it was found that 
rats responded to stimulation of the olfactory tract (leading to the piriform cortex) as if it were a 
specific odorant stimulus (Roman et al., 1987).  Rats could then learn to discriminate different 
types of stimulation (i.e. odor surrogates) in a process that produced significant long-term 
potentiation (LTP) in the piriform cortex (Roman et al., 1987; Litaudon et al., 1997), suggesting 
that the piriform cortex may be a critical step in the acquisition of olfactory memories.   
Information processed in the piriform cortex is projected to the tertiary region of 
olfactory processing, the orbitofrontal cortex (OFC; Fig. 1-2).  The orbitofrontal cortex receives 
converging multimodal information, yet is the primary region of olfactory processing in the 
neocortex.  The OFC receives olfactory information directly from the piriform cortex and 
indirectly through the thalamus (Shepherd, 2007).  Electrophysiological studies reveal that the 
OFC encodes a greater degree of associative content than that found in the APC (Roesch et al., 
2007) with similar results found through c-Fos immunolabeling (Tronel and Sara, 2002).  
Lesions to the OFC do not impair odor discrimination or the ability to form simple odor 
memories; however, a significant impairment is found in higher-order cognitive functions such 
as overcoming a learned non-reward (Tait and Brown, 2007).  In a human fMRI study it was 
 15 
revealed that banana odor-induced OFC activity was reduced after bananas were consumed to 
satiety; however, the OFC response to a control odorant (vanilla) remained unchanged after 
banana consumption (O'Doherty et al., 2000), indicating that the OFC influences the cognitive 
salience of olfactory information.  Taken together, these studies demonstrate a transition in the 
content of olfactory information as it ascends from the olfactory bulb, up through the anterior 
piriform cortex to the orbitofrontal cortex.  The function of brain activity in these three regions 
will be the focus of our histological studies. 
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2.0  IMMUNOHISTOCHEMICAL CONSOLIDATION OF ANESTHESIA-PAIRED 
STIMULI IN THE ABSENCE OF BEHAVIORAL RECALL 
2.1 INTRODUCTION 
Two of the defining characteristics of an anesthetic are the ability to induce both a loss of 
consciousness and amnesia.  Prior to the use of diethyl ether as a surgical anesthetic, pioneering 
anesthesiologists noticed that individuals participating in ‘ether frolics’ were left with no 
memory of the event (Fenster, 2001).  Since then, general anesthesia has thoroughly been shown 
to impair or prevent learning and memory formation (Weinberger et al., 1984; el-Zahaby et al., 
1994; Rich et al., 1999; Antognini and Carstens, 2002; Alkire and Gorski, 2004; Bekinschtein et 
al., 2009).  Despite the absence of memory, information is still transmitted.  Brain imaging in 
humans has revealed that stimuli presented during deep anesthesia can still reach higher cortical 
areas, albeit to a lesser degree (Bonhomme et al., 2001; Veselis et al., 2005).  Rodent 
electrophysiological studies in the primary region of olfactory processing (the olfactory bulb) 
have revealed that anesthesia does not interrupt the neural response to an odorant, but actually 
improves the signal to noise ratio (Rinberg et al., 2006).  Odor responsive neurons were shown to 
persist during recordings in secondary and tertiary regions of olfactory processing despite 
anesthesia (Nemitz and Goldberg, 1983; Onoda et al., 1984; Murakami et al., 2005), suggesting 
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that entire pathways can retain a certain level of function.  We were therefore interested whether 
changes in gene expression would reflect stimuli administered during general anesthesia. 
Early studies found that administration of protein-synthesis inhibitors prior to, or shortly 
after, learning prevented memory formation (Agranoff et al., 1965; Barondes and Cohen, 1966, 
1967; Hernandez and Abel, 2008).  This work has revealed a window of protein synthesis critical 
to memory formation termed the ‘consolidation’ period (Sara, 2000; Sara and Hars, 2006).  In 
order to elucidate molecular events underlying memory consolidation, we investigated the 
expression of immediate early genes during this period.  Immediate early genes (IEGs) are a 
group of rapidly and transiently activated genes that reflect some level of neural activity (Sheng 
and Greenberg, 1990; Guzowski, 2002).  The transcription factor-encoding IEG, c-fos, was 
examined as this gene has been shown to be critical in memory formation (Paylor et al., 1994; 
Grimm et al., 1997; Fleischmann et al., 2003).  c-fos is a proto-oncogene whose gene product, c-
Fos, dimerizes with Jun proteins to form the AP-1 (activator protein-1) complex which 
upregulates a wide variety of genes (Sheng and Greenberg, 1990). The expression of c-fos was 
compared to that of another immediate early gene, egr1, which has been previously used as a 
marker of neural activation (Inaki et al., 2002; Mandairon et al., 2008).  In this part of the 
investigation we studied whether the immunohistochemical changes associated with novel 
odorant exposure in the awake rat brain occurred similarly to that in the anesthetized animal.  We 
have found that c-Fos expression may reflect the mechanisms of olfactory memory consolidation 
and that this processes occurs despite presentation of the odorants during the unconscious, 
anesthetized state. 
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2.2 MATERIALS AND METHODS 
2.2.1 Experimental Animals 
For all experiments, 7-week old male Sprague Dawley rats were purchased from Harlan 
Laboratories (Indianapolis, IN).  Animals were maintained in a controlled temperature (20-22ºC) 
and humidity environment with a constant 12:12 light-dark cycle (on 07:00 - 19:00 hr).  Animals 
were individually housed to minimize incidental odors and allowed one week to acclimate to the 
colony and odor environment prior to treatment.  The environmental odors in the housing facility 
were also strictly controlled to minimize any variation.  Food and water were available ad 
libitum.  All experimental protocols were approved by the Institutional Animal Care and Use 
Committee at the University of Pittsburgh. 
2.2.2 Experiment A:  Six day training paradigm 






A1 AIR Awake SNT Awake 7 
A2 AIR Awake SNT Anes 8 
A3 SNT Awake SNT Awake 7 
A4 AIR Awake AIR Anes 8 
A5 Naïve Naïve 8 




All procedures were performed inside a hard-ducted flow hood which vented directly to the 
exterior of the building in order to control incidental odors and preserve odorant novelty.  Utmost 
caution was used to control all odors in the environment, and surfaces were cleaned thoroughly 
between trials with 70% ethanol then again with water.  A clean, empty, typical rat cage 
(Allentown, Allentown, NJ) was used for the each trial.  The lid and wire food grate were 
removed and replaced with a plate of glass that covered the cage and allowed filming from 
above.  A 1x1” grid was placed beneath the cage to facilitate behavioral scoring.  The grid could 
be seen through the clear plastic caging and was visible to the camera.  In experiment ‘A’, rats 
were trained for six consecutive days and tested on the seventh day.  Training and testing 
occurred as described in Table 2-1.  Experimental animals were either awake (Awake) or 
anesthetized (Anes) and received either the scent (SNT) or no scent (AIR).  A naïve group did 
not receive any treatments, but was sacrificed immediately after removal from the home cage.  
All animals received either anesthesia or saline (0.3ml) injections prior to each trial.  For 
ubiquitous bulbar activation, the scent used was an equal mixture of 6 different odorants.  These 
odorants were obtained from Sigma (St. Louis, MO) and included:  isoamyl acetate, cineole, 
octanol, decanal, capronaldehyde, and R-(-)-carvone.  A total of 38 animals were used in the 
experiment.   
One day prior to training, rats were allowed to acclimate to the novel cage environment 
for 30 minutes.  An empty, capless 1.5 ml Eppendorf (Hauppauge, NY) tube was placed in the 
center of the cage halfway through to allow the rat to familiarize itself with the object before 
being returned to its home cage.  During training on the following day, rats were placed in a new 
cage and allowed to acclimate to the environment for 20 minutes with an empty Eppendorf tube.  
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After 20 minutes, the empty tube was removed, filming was initiated and either a scent-filled or a 
new empty tube was reintroduced.  Awake rats in the ‘SNT’ condition were given a capless 1.5 
ml Eppendorf tube filled with 35 µl of the undiluted odorant mixture injected into a small piece 
of cotton at the bottom of the tube which acted as a reservoir for the odorants. Tubes filled with 
the odorant mixture were prepared ahead of time and stored in an air-tight container.  Rats in the 
‘AIR’ condition were given a similar tube that did not contain the odorants.  Tubes were placed 
in the opposite corner relative to the rat’s location.  The animals were allowed to freely interact 
with the respective tube for 20 minutes, after which the tube and lid were removed and replaced 
with a wire grate for 15 min to allow the removal of any lingering odors by the flow hood.  
Anesthetized rats receiving the odorant mixture were placed flat on their stomachs with the 
odorant-filled tube placed approximately 1-inch from the snout.  10 min into the exposure, the 
tube was removed and the animal tested for depth of anesthesia, after which the tube was 
returned to its original location for the duration of the exposure.  To provide warmth and prevent 
hypothermia heating pads were placed under the animal’s cage and a lamp was positioned above 
the animal.  Body temperature was monitored with a digital rectal thermometer (VWR, Arlington 
Heights, IL) and maintained between 36-38ºC through the positioning and intensity of heat 
sources.  Following odorant exposure, the rat was transferred to a new empty cage for 15 minutes 
to allow the removal of residual odors by the hood.  Anesthetized rats in the ‘AIR’ condition 
were not given a tube, but were otherwise treated identically.  Rats were then returned to their 
home cage where body temperature was similarly monitored and maintained prior to waking up 
from anesthesia.   
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2.2.2.2 Behavioral Analysis 
Behavioral videos were manually scored in parallel by blinded observers.  The duration of 
rearing and tube-directed smelling behaviors within 1” of the tube was quantified.  The latency 
of rats to approach the tube was also assessed and capped at a maximum of 30 seconds.  
Movement was manually scored, again by blinded observers, over the entire video (first 7 
minutes of 20 minute exposure period).  Movement was assessed by the total number of times 
the base of the tail (border of fur and furless regions) broke a line in the 1x1” grid positioned 
underneath the cage.  Repetitive, stereotyped back-and-forth line breaks were not counted.  Only 
major ambulatory movements involving two or more consecutive line-breaks were counted. 
2.2.3 Experiment B:  Single day training (Odor Attenuation Task) 








B1 AIR & Awake AIR Awake AIR Awake 6 
B2 AIR & Awake AIR Awake SNT Awake 6 
B3 AIR & Awake SNT Awake SNT Awake 7 
B4 AIR & Awake AIR Anes SNT Awake 6 
B5 AIR & Awake SNT Anes SNT Awake 6 
      Total = 31 
2.2.3.1 Procedure 
We developed a novel behavioral task entitled the ‘Odor Attenuation Task’ for testing odor 
familiarity related to that described previously (Mandairon et al., 2008).  These experiments were 
conducted in the Rodent Behavioral Animal Core (RBAC) of the University of Pittsburgh.  
Experiments occurred in the dark with red-light illumination.  A custom built 17x17” black 
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Plexiglas floor was constructed to fit inside an open field activity monitor (model ENV-515, 
Med Associates, St. Albans, VT) of the same dimensions.  A removable black Plexiglas 
cartridge, 2” in diameter, was positioned in the center of the floor, the profile of which acted as 
the ‘odorant zone’.  A 0.8cm hole in the center of the cartridge allowed the rodent indirect access 
to an odorant-containing tube (1.5ml Eppendorf, Hauppauge, NY) positioned within the 
cartridge.  The cartridge lay flush to the floor such that the animal could only detect the central 
hole.  A clear Plexiglas lid was placed atop the activity monitor to contain the odorants within 
the chamber and allow for video recording from above.  Groups of rats received scent (SNT) or 
no scent (AIR) while awake (Awake) or anesthetized (Anes) during training and testing days as 
described in Table 2-2.  The scent utilized was the same odorant combination described in 
experiment ‘A’.  All animals not receiving intraperitoneal injection of anesthesia were given 
0.3ml saline injection 30 min prior to any behavioral work each day.  All animals received saline 
injections on the habituation and test days.  A total of 31 animals were used for the experiment. 
Rats received a day of handling then three days of habituation in the chambers for twenty 
minutes each day.  Halfway through the habituation, the cartridge was removed, the tube 
replaced with a new empty tube, and the cartridge was re-inserted.  On training and testing days, 
rats were first acclimated to the chamber with an empty tube in the cartridge for 15 minutes.  
After which, the cartridge was removed and the tube replaced with either an odorant-containing 
tube or a similar empty tube.  During this experimental phase the rat was allowed to freely 
explore for a period of 5 minutes.  The odorant mixture used during this period was diluted 
1:1000 in mineral oil (Sigma-Aldrich, St. Louis, MO).  35 µl of the diluted mixture was injected 
into a cotton reservoir at the bottom of a 1.5ml Eppendorf tube.  A diluted odorant mixture was 
used for the behavioral test to encourage a prolonged and direct smelling behavior, and to 
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minimize odor contamination of the training apparatus.  Tubes filled with the odorant mixture 
were prepared ahead of time and stored in an air-tight container.  Caution was used to prevent 
incidental premature exposure to the odorants.   
After the 5 minute trial animals were briefly returned to their home cage.  They were then 
transferred to a clean, empty rat cage within a hard-ducted hood in a nearby room.  Two tubes of 
the undiluted odorants, or two empty tubes, were then placed in opposite corners of the cage to 
prevent an odor gradient.  The rat was allowed to freely interact with the tubes for 20 minutes.  
An undiluted odorant mixture was used in this phase of the experiment to mimic the potent 
exposure in experiment ‘A’.  After exposure, rats were aired off in a separate cage for 15 minutes 
before being returned to their home cages.  Several hours prior to receiving anesthesia on the 
training day, rats in the ‘Anes’ group first received an additional day of habituation to the 
behavioral chamber to ensure equal familiarity with the other groups.  Later the animals were 
anesthetized and placed directly in an empty cage within the hard-ducted hood for exposure to 
the undiluted odorants.  These animals received a pulsatile odorant exposure to mimic odor 
exploration while awake.  Rats received 10 seconds of potent exposure (tube 1” from snout) in 
the beginning, middle and end of the 20 minute period, and received moderate exposure (tube ≥ 
5” from snout) for the remainder of the time.  No tubes were used for anesthetized rats in the 
‘AIR’ condition, but they were otherwise treated identically.  Anesthetized animals were then 
allowed to air off in the hood for 15 minutes before being transferred back to their home cages.  
All rats given anesthesia were kept warm through the use of lamps positioned above the cage and 
heating pads positioned underneath the cage.  Techniques established to maintain body 
temperature between 36-38ºC in experiment ‘A’ were again utilized in experiment ‘B’; however, 
direct measure of body temperature was not assessed.   
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 Figure 2-1.  Representative path traces demonstrating avoidance of the central chamber region. 
Ambulatory traces of the rat body over the 15 minute habituation period just prior to familiarity testing.  The 
majority of time was spent in the corners or along the walls of the chamber; however, most animals appeared willing 
to enter or cross the central region. 
 
2.2.3.2 Behavioral Analysis 
Video was acquired and analyzed using Limelight automated tracking software (v3.0; 
Actimetrics, Wilmette, IL) with black and white CCD cameras (Panasonic, Secaucus, NJ).  Nose, 
body and tail locations were tracked using the software, and time of the nose within the pre-
defined odorant zone was quantified automatically for the first 10, 30 and 100 seconds from 
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approach.  To confirm automated analysis, videos were manually scored for smelling behaviors 
by two blinded observers (see Appendix A, Fig. A-1).  The latency of rats to approach the 
odorant zone was assessed and capped at a maximum of 30 seconds.  All animals in this 
experiment approached the odorant zone within the time allowed for the trial (5 minutes).  Pilot 
studies found that rats typically avoided the central and most exposed region of the chamber 
when the experimental odorants were not present (data from habituation phase; Fig. 2-1). 
2.2.4 Anesthesia 
To ensure a uniform physiological state, rats were deeply anesthetized until they reached a 
surgical depth of anesthesia.  ‘Surgical depth’ was defined as decreased respiration rate and 
depth, decreased muscle tone and absence of response to a noxious (repetitive toe pinch) 
stimulus.  Skin color was also used as an indirect measure of blood oxygenation.  The anesthetic 
used was intraperitoneal injection of ketamine (Ketaset, Fort Dodge, Fort Dodge, IA; 100mg/ml) 
and xylazine (Anased, Lloyd Laboratories, Shenandoah, IA; 100mg/ml).  An initial dose of 
anesthesia was used to immobilize the animals and subsequent booster injections were given 
until the appropriate plane of anesthesia was reached.  Rats were given an average dose of 148.0 
± 13.7 mg/kg ketamine and 19.7 ± 1.8 mg/kg xylazine over an approximate 30 minute period in 
experiment ‘A’ and 162.6 ± 10.7 mg/kg ketamine and 21.8 ± 1.4 mg/kg xylazine in experiment 
‘B’.  No significant differences were found between group averages for anesthetic dose 
administered in either experiment.  Doses of ketamine and xylazine (± Standard Error, S.E.) by 
group for each trial in experiments A and B are represented in Table 2-3.   
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Table 2-3  Average dose of ketamine/xylazine anesthesia (mg/kg ketamine, xylazine ± S.E.). 
 
Group Train TEST 
A2  125.1 ±13.5, 16.7 ±1.7 
A4  170.8 ±22.4, 22.8 ±3.0 
B4 159.7 ±19.0, 21.4 ±2.5  
B5 165.6 ±11.6, 22.2 ±1.6  
 
2.2.5 Immunohistochemistry 
Two hours after odorant/air exposure on the testing day, animals were sacrificed with anesthetic 
overdose and perfused with a solution of 4% paraformaldehyde in phosphate buffered saline 
(PBS; pH 7.0).  Brains were post-fixed overnight and cryoprotected in a 30% sucrose/PBS 
solution with 0.01% sodium azide as a preservative.  50µm sections (experiment A) and 30µm 
sections (experiment B) were generated using a sliding microtome (Leica, Buffalo Grove, IL) 
equipped with a freezing stage (Physitemp Instruments, Clifton, NJ).  Tissue was prepared for 
either brightfield or fluorescent microscopy.  Sections were blocked with 10% donkey blocking 
buffer (PBS with 10% donkey serum and 0.2% Triton X-100) for 2 hours at room temperature.  
Primary antibodies against c-Fos (Calbiochem-EMD Biosciences, San Diego, CA; 1:5000), Egr1 
(Cell Signaling, Boston, MA; 1:10,000), NeuN (Chemicon-Millipore, Billerica, MA) and/or 
GAD67 (Abcam, Cambridge, MA) were diluted in donkey blocking buffer and incubated with 
free-floating sections overnight at 4ºC.   
Sections for brightfield microscopy were then washed with PBS and incubated in a 
biotinylated goat secondary antibody (1:1000 in DBB; Dako, Carpinteria, CA) for 2h at room 
temperature, followed by an avidin-peroxidase wash (1:1000 in DBB; Sigma, St. Louis, MO) for 
1h.  Enzymatic reaction with DAB (3,3’-Diaminobenzidine; Sigma) was performed until sections 
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reached optimal darkness (1-3 minutes).  Sections were then dehydrated in a series of ethanol 
and xylene solutions, mounted on glass slides and cover slipped using Eukitt mounting medium 
(Electron Microscopy Sciences; Hatfield, PA).   
Sections for fluorescent microscopy, after treatment with primary antibodies, were 
washed in PBS and incubated with Alexa Fluor 594 and/or 488-conjugated secondary antibodies 
(Invitrogen, Carlsbad, CA; 1:500) in the dark.  Sections were co-stained with the nuclear marker 
DAPI (4',6-diamidino-2-phenylindole; Sigma), washed and mounted onto slides using 
fluoromount-G mounting medium (SouthernBiotech, Birmingham, AL). 
2.2.6 Quantification 
Staining was imaged using an Olympus IX-81 widefield microscope equipped with a color 
Retiga 2000R (QImaging, Surrey, BC, Canada) and monochrome ORCA-ER (Hamamatsu, 
Bridgewater, NJ) peltier-cooled CCD cameras.  Images were acquired and analyzed using 
Image-Pro Plus (Media Cybernetics, Bethesda, MD) software.  For DAB-labeled sections the 
optical fractionator method (King et al., 2002) was used to quantify each region.  Every sixth 
section was quantified, using this stereology technique, in the anterior piriform cortex and lateral 
orbitofrontal cortex (from bregma +3.1mm to +3.7mm, rostrocaudal) (Paxinos and Watson, 
1998; Swanson, 1998).  In the olfactory bulb, sections at +6.8mm and +7.9mm rostrocaudal 
bregma were quantified and used to estimate the positive cell number in the bulb.  Positive 
labeling in DAB sections was represented as total or average number of positive cells.  
Fluorescent images were acquired under identical settings and uniformly quantified by a 
threshold method.  They were additionally screened by a set size and subjected to a watershed 
split function.  Comparisons were made only between sections stained and imaged in the same 
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session.  Sections for fluorescent c-Fos and Egr1 imaging were taken from +3.5mm, +3.3mm 
and +3.1mm rostrocaudal bregma in the cortex.  Positive labeling in fluorescent tissue was 
represented as positive cell number per mm2.  Double-labeling c-Fos/NeuN and c-Fos/GAD67 
experiments utilized sections from +3.3mm rostrocaudal bregma in the cortex.  Labeling of c-
Fos/NeuN was quantified using the threshold method; however, c-Fos/GAD67 double-labeled 
sections had to be manually counted (in a blinded manner) due to the non-nuclear nature of the 
GAD67 antibody labeling.   
2.2.7 Statistical Analysis 
One-way ANOVA was used to determine a significant overall difference followed by Tukey’s 
post hoc analysis for inter-group comparison.  For other analyses, two-way ANOVA was used 
followed by a Bonferroni posttest.  A student’s t-test was utilized for experiments containing 
only two groups.  Values are described as group means ± standard error. For all analyses, 
differences were considered significant when p < 0.05. 
2.3 RESULTS 
2.3.1 Absence of memory recall for anesthesia-paired odorants 
To confirm the effects of anesthesia on memory for our novel odor attenuation task, rats were 
fully anesthetized and presented a novel odorant mixture during training.  These rats were then 
tested for familiarity with the odorants 24 hours later during the test trial (Fig. 2-2).  One-way 
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ANOVA of odor investigation times (first 30 seconds after approach) for all cohorts in 
experiment ‘B’ produced a significant group effect (F(4,25) = 9.039; p < 0.001) during the 
automatically scored TEST trial (Fig. 2-2B).  Tukey post-hoc test appeared to reveal two distinct 
behavioral phenotypes.  Repeated exposure to the same odorant mixture (SNT-SNT, group B3) 
produced a significantly attenuated behavioral response relative to a single exposure (AIR-SNT, 
B2; tukey posttest, p < 0.05).  Thus, rats previously exposed to the odorants appeared less 
interested in the odor stimulus (familiar response) relative to rats that experienced the odorants 
for the first time (novelty response).  Importantly, rats that received the odorant mixture and 
anesthesia on the training day, then the odorant mixture while awake on the testing day 
(SNT(Anes)-SNT, B5) were significantly different than rats that were tested with air (AIR-AIR, 
B1; p ≤ 0.01, tukey posttest) or familiar odorants (SNT-SNT, B3; p ≤ 0.01, tukey posttest).  
These animals (SNT(Anes)-SNT, B5) were not significantly different than rats that received the 
novel odorant mixture after training with air (AIR-SNT, B2; p = 0.998) or after training with air 
and anesthesia (group AIR(Anes)-SNT, B4; p = 1.00).  Blinded manual scoring (Fig. 2-2C) 
confirmed these data produced by the tracking software.  Likewise, a similar pattern was found 
when behavioral data were assessed at different time periods (first 10s or 100s after approach), 
which could also be visualized through representative path traces (see Appendix A).  These 
findings suggest that rats are unable to retrieve the memory of an odorant if the odorant was 










Figure 2-2.  Absence of memory for odorants experienced during general anesthesia. 
Behavioral familiarity with the odorant mixture was assessed by duration of odor investigation time.  (A) Time 
course of odor response on the final habituation, training and testing trials.  Test trial data from (A) is replotted in 
bar graph form in (B).  (B) Smelling duration was determined by the duration of time the snout was within the 
odorant zone scored automatically within the first 30 seconds after approach.  (C) Manual confirmation of 
automatically scored data by blinded observers.  Data from experiment ‘B’.  (*) p < 0.05 relative to AIR-SNT, one-




2.3.2 Immediate-early gene product, c-Fos, reflects consolidation 
In attempt to address the mechanisms of consolidation, we first looked at the pattern of IEG 
expression in the olfactory cortical regions of awake, odorant-exposed rats.  Protein expression 
was assessed in the primary (Olfactory Bulb, OB), secondary (Anterior Piriform Cortex, APC) 
and tertiary (Orbitofrontal Cortex, OFC) regions of olfactory processing (Shepherd, 2007) 
experiment ‘A’ (Fig. 2-3). Immediate early genes were selected as these genes have been 
suggested to play a role in memory consolidation (Rose, 1991).  Specifically, we wanted to 
investigate any potential differences between the IEG response during the period of initial 
consolidation (following a novel odor, group A1) and the post-consolidation period (following a 
familiar odor, group A3).  Naïve animals (A5) were included in figure 2-3 as a negative control.  
One-way ANOVAs of all groups in experiment ‘A’ were performed on each brain region for the 
immediate early gene products, c-Fos and Egr1.  Significant group effects were found for both c-
Fos and Egr1 in each brain region (see Table 2-4 for specific F and p values).   
 
Table 2-4.  One-way ANOVA F and p values for all regions and antibodies 
c-Fos Egr1 

















p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.001 p < 0.0001 p < 0.0001 p < 0.0001 
 
Tukey post-hoc comparison of c-Fos labeling revealed a significant effect between rats receiving 
novel (AIR-SNT, A1) and familiar odorant mixtures (SNT-SNT, A3) in the granule cell (OB-
GCL) and mitral cell layers (OB-ML) of the olfactory bulb (p < 0.001 and p ≤ 0.05, respectively) 
but not in orbitofrontal cortex (p = 0.86; Fig. 2-3A).  A trend was found in the anterior piriform 
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cortex (p = 0.10), suggesting a potential effect in this region as well.  No significant differences 
were found between novel (AIR-SNT, A1) and familiar (SNT-SNT, A3) odorant mixtures for 
Egr1 expression in any of the brain regions assessed (Fig. 2-3B).  However, naïve (no odor, A5) 
rats demonstrated significantly less Egr1 expression than both novel and familiar odor groups 
(A1 and A3) in all regions (p < 0.05 for each pair-wise comparison).  The preferential expression 
of c-Fos for novel stimuli suggests that this gene is activated during times of memory formation 
and thus may reflect some level of information consolidation in olfactory-related cortical 
regions.  Egr1, on the other hand, appears to indicate the presence of absence of a stimulus. 
 
 
Figure 2-3.  Preferential expression of c-Fos during periods of consolidation. 
Differential c-Fos (A) and Egr1 (B) expression following novel (AIR-SNT), familiar (SNT-SNT) or no (naïve) odor 
in the primary [OB(GCL) & OB(ML)], secondary (APC) and tertiary (OFC) regions of olfactory processing.  Data 
from experiment ‘A’.  (*) p < 0.05 between novel and familiar odors, one-way ANOVA with Tukey post hoc test.  
GCL = Granule Cell Layer of olfactory bulb; ML = Mitral Layer of olfactory bulb. 
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2.3.3 Time-course of c-Fos mirrors behavior 
Previous studies have found that expression of immediate early genes, including c-fos, were 
attenuated following a week of repeated odorant exposure, for twenty minutes each day, relative 
to a single exposure (Montag-Sallaz and Buonviso, 2002) a finding that we have confirmed in a 
number of olfactory processing regions (Fig. 2-3A).  These studies may suggest that one week of 
repeated odorant is required to produce c-Fos attenuation.  However, comparison of behavioral 
data for novel (AIR-SNT, A1) and familiar (SNT-SNT, A3) odorant exposures revealed that 
odor familiarity is acquired on a shorter time-scale.  Two-way ANOVA of behavioral data from 
animals with six days of training (Experiment A) revealed a significant effect of treatment day 
and the interaction of date and condition (p < 0.0001 for both).  Bonferonni post hoc test 
revealed a significant effect between animals in the novel (AIR-SNT, A1) and familiar (SNT-
SNT, A3) odor groups on training day 1 (p < 0.001) and on the test day (p < 0.001).  
Interestingly, by training day 2, animals receiving a familiar odorant mixture (SNT-SNT; A3) 
were not significantly different than those receiving only air (AIR-SNT, A1).  In short, the 
rodents appeared to be behaviorally familiar with the odorants after only one day, as opposed to 
one week, of exposure.   
If c-Fos expression were to reflect some level of memory consolidation, we might expect 
to see these histological changes occur on the same time-scale as the behavior changes, which 
require merely a single exposure.  In experiment ‘B’, rats received only a single day of the 
odorant mixture (or air) prior to testing.  Comparison of behavioral data from experiment ‘A’ 
(Fig. 2-4, top) and histological data from experiment ‘B’ (Fig. 2-4, red arrow) allows us to 
determine whether c-Fos expression reflects behavioral measures.  If c-Fos is attenuated after 
only a single prior exposure, this would suggest that the temporal expression profile of c-Fos 
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protein is appropriate for that of a consolidation marker.  Analysis of c-Fos histological data 
(one-way ANOVA) from experiment ‘B’ indeed reveals a significant group effect in the APC 
and OFC (F(4,26) = 5.98, p < 0.01 and F(4,26) = 6.96, p < 0.001, respectively).  Inter-group 
comparison (tukey posttest) reveals a difference between novel (AIR-SNT, B2) and familiar 
(SNT-SNT, B3) odorant exposures already by day 2 for the APC (p < 0.05) and OFC (p < 0.01).  
Furthermore, the c-Fos attenuation with familiar odorants appears more robust after a single 
exposure than following seven days of repeated exposure, especially in the OFC (Fig. 2-4, grey 
arrow).  On day 2, the average expression of c-Fos with a familiar odorant was attenuated to 
54.5% of a novel odorant in the APC and 29.6% of a novel odorant in the OFC.  On day 7, 
expression was attenuated to 57.5% in the APC and only 82.3% in the OFC.  These data suggest 
that memory formation and changes in c-Fos histology occur in a similar temporal manner.  In 
addition to changes in expression level (Fig. 2-3), the IEG, c-Fos, is also expressed in the 














Figure 2-4.  Expression of c-Fos matches time-course of memory acquisition. 
(Top) Rats receiving 7 days of repeated odorant (SNT-SNT or familiar odor) in experiment ‘A’ displayed behavioral 
familiarity with the odorant by training day 2.  Corresponding histology of these animals (bottom, grey arrow) 
revealed significantly attenuated c-Fos in the APC after 7 days of repeated odorant.  However, in experiment ‘B’ 
(bottom, red arrow) we found that c-Fos expression was attenuated in the APC and OFC after only 2 days of 
repeated odorant, a time-point that matches behavioral habituation to the odor in experiment ‘A’.  Data from 
experiments ‘A’ & ‘B’.  (*) p < 0.05, two-way ANOVA with bonferonni post hoc test, top; one-way ANOVA with 
tukey posttest, bottom. Note: different quantification techniques used for experiments ‘A’ and ‘B’.   
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2.3.4 Possible consolidation during general anesthesia 
Given the expression profiles of c-Fos and Egr1 in the awake, odor-exposed rat (Fig 2-3), we 
assessed the pattern of these IEGs when the odorant mixture was presented in the anesthetized 
state (experiment ‘A’).  Rats receiving anesthesia and a novel odorant mixture (AIR-SNT(Anes), 
group A2) were represented alongside those receiving anesthesia alone (AIR-AIR(Anes), A4) as 
well as positive (novel odor; AIR-SNT, A1) and negative controls (naïve animals, A5; Fig. 2-5).  
One-way ANOVA of all groups in experiment ‘A’ revealed a significant group effect in the 
anterior piriform cortex (secondary region of olfactory processing) for both c-Fos (F(4,33) = 11.84; 
p < 0.0001) and Egr1 protein (F(4,33) = 16.14; p < 0.0001).  Interestingly, Tukey post-hoc test 
revealed a significant difference (p < 0.05) in c-Fos labeling between rats that received a novel 
odorant mixture during anesthesia (AIR-SNT(Anes), A2) and rats that received anesthesia alone 
(AIR-AIR(Anes), A4).  No differences were found between rats who received the odorants while 
anesthetized (AIR-SNT(Anes), A2) and rats that received the odorants while awake (AIR-SNT 
group, A1; p = 0.82).  Egr1 expression did not differ between animals who received a novel 
odorant mixture during anesthesia (AIR-SNT(Anes), A2) and those who received anesthesia 
alone (AIR-AIR(Anes), A4).   
Our findings also revealed significant group effects in the orbitofrontal cortex (tertiary 
region of olfactory processing) for both c-Fos (F(4,33) = 10.64; p < 0.0001) and Egr1 (F(4,33) = 
28.36; p < 0.0001; Fig. 2-6) as shown by one-way ANOVA.  Inter-group comparison did not 
reveal a significant effect of c-Fos labeling between anesthetized rats who received the odorants 
(AIR-SNT(Anes), A2) and those that did not (AIR-AIR(Anes), A4; p = 0.30).  In this case, a 
trend was observed between rats who received the odorants during anesthesia (AIR-SNT(Anes), 
A2) and rats who received the odorants during the awake state (AIR-SNT, A1; p = 0.065).  
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Again, Egr1 expression did not differ between those who received the novel odorant mixture 




Figure 2-5.  Elevated c-Fos elicited by olfactory stimuli during anesthesia in the APC. 
Representative photomicrographs (top) of c-Fos and Egr1 immunolabeling in the anterior piriform cortex.  
Corresponding c-Fos (bottom-left) and Egr1 (bottom-right) stereological quantification.  Data from experiment ‘A’.  







Figure 2-6.  Elevated c-Fos elicited by olfactory stimuli during anesthesia in the OFC. 
Representative photomicrographs (top) of c-Fos and Egr1 immunolabeling in the orbitofrontal cortex.  
Corresponding c-Fos (bottom-left) and Egr1 (bottom-right) stereological quantification.  Data from experiment ‘A’.  




No significant differences were seen in olfactory bulb c-Fos labeling between 
anesthetized animals with (AIR-SNT(Anes), A2) and without (AIR-AIR(Anes), A4) exposure to 
the odorant mixture in either the granule cell layer or mitral layer (Fig. 2-7).  These data suggest 
that some level of information consolidation can occur when olfactory stimuli are presented in 
the deeply anesthetized state.  These changes occurred in the secondary region of olfactory 
processing (APC) but not in the primary or tertiary regions of olfactory processing (OB and 





Figure 2-7.  No evidence of consolidation in the olfactory bulb. 
Quantification of c-Fos protein expression in the granule cell layer (A) and mitral layer (B) of the rat olfactory bulb.  






2.3.5 Traces of consolidation following general anesthesia 
If olfactory stimuli caused c-Fos activation under general anesthesia, it is possible that long-term 
changes took place to reflect that information.  To determine if this olfactory information was 
stored, we investigated whether stimuli received under general anesthesia would later be reported 
as novel or familiar through c-Fos histology.  Histological data in experiment ‘B’ is presented 
juxtapose to behavioral data (Fig. 2-8A, B) for the same animals.  Rats who received a novel 
odorant mixture while anesthetized during training then received the same odorants again while 
awake on the test day (SNT(Anes)-SNT, group B5) were compared with rats who received 
anesthesia alone during training and the novel odorant mixture during testing (AIR(Anes)-SNT, 
B4), along with novel (AIR-SNT, B2), familiar (SNT-SNT, B3), and no odorant (AIR-AIR, B1) 
groups.  One-way ANOVA of c-Fos labeling revealed a significant group effect in the anterior 
piriform (F(4,26) = 5.98; p < 0.01) and orbitofrontal cortices (F(4,26) = 6.96; p < 0.001; Fig 2-8).  
Post-hoc analysis revealed a significant difference between novel (AIR-SNT, B2) and familiar 
(SNT-SNT, B3) odor groups in the APC (p < 0.05; Fig. 2-8C) and OFC (p < 0.01; Fig. 2-8D), a 
pattern that is reflected in the behavioral data (Fig. 2-2B).   
Interestingly, the SNT(Anes)-SNT group (B5) was significantly attenuated relative to the 
novel odor group (AIR-SNT, B2) in both the APC and OFC (p < 0.01 for both).  Unlike the 
SNT(Anes)-SNT (B5) group, AIR(Anes)-SNT (B4) animals did not differ significantly from the 
animals receiving novel odorants (AIR-SNT, B2) in either the APC or OFC.  Furthermore, in the 
orbitofrontal cortex the SNT(Anes)-SNT (B5) group was significantly different than the 
AIR(Anes)-SNT group (B4; p < 0.05; Fig. 2-8D).  In these regions, the pattern of c-Fos 
expression for novel and familiar odorants appeared similar regardless of prior anesthesia 
exposure, a pattern dissimilar to that found behaviorally.  These findings indicate that an odorant 
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mixture presented during ketamine/xylazine anesthesia produces a histological imprint capable 
of impacting subsequent gene expression.  Egr1 immunolabeling in these two regions did not 




Figure 2-8.  Evidence of histological memory trace for anesthesia-paired stimuli – comparison with behavior. 
Behavioral familiarity with the odorant stimulus on the test trial (A,B) and quantification of c-Fos protein expression 
in the anterior piriform (C) and orbitofrontal (D) cortices following the test trial.  Test trial only data from (A) 
replotted in bar graph form in (B).  Data from experiment ‘B’.  (*) p < 0.05 relative to AIR-SNT; (†) p < 0.05 
relative to AIR(Anes)-SNT, one-way ANOVA with Tukey post hoc test.  ‘Hab. 3’ = Habituation day 3. 
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2.3.6 Differences between Ketamine/Xylazine and Odor-induced c-Fos 
Knowing that both the odorant mixture and ketamine/xylazine anesthesia were able to induce c-
Fos expression, we were interested to see whether different sub-populations of cells were 
activated by these different stimuli.  To ensure that the c-Fos-positive cells were indeed neurons, 
we double-labeled sections from rats receiving the odorant mixture alone (AIR-SNT, A1), the 
odorant mixture and anesthesia (AIR-SNT(Anes), A2) or anesthesia alone (AIR-AIR(Anes), A4) 
from experiment ‘A’ with antibodies against c-Fos and NeuN, a marker of mature neurons.  We 
found that the vast majority of c-Fos-labeled cells were also mature neurons (Fig. 2-9).  Across 
all groups, the average percent of c-Fos-positive cells that were also positive for NeuN was 
95.5% ± 1.3 in the APC and 88.3% ± 5.1 in the OFC.  One-way ANOVA of these groups 
revealed a significant group effect in the anterior piriform cortex (F(2,6) = 5.28; p < 0.05).  Tukey 
post-hoc test revealed a significant difference between rats who received a novel odorant mixture 
(AIR-SNT, A1) and rats who received anesthesia alone (AIR-AIR(Anes), A5; p < 0.05).  No 
significant effects were found in the orbitofrontal cortex. 
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 Figure 2-9.  Overlay of c-Fos and NeuN expression in the APC and OFC. 
Representative fluorescent micrographs of c-Fos (red) and NeuN (green) double-labeling in the APC (A) and OFC 
(B).  Corresponding monochrome NeuN images are represented in (C) and (D), respectively.  Quantification of 
double-labeled c-Fos/NeuN+ cells is represented for the APC (E) and OFC (F).  The height of each bar indicates the 
total density of c-Fos+ cells.  The percentage indicated over each bar represents the density of double-labeled c-
Fos/NeuN+ cells relative to the total density of c-Fos+ cells.  Data from experiment ‘A’.  (*) p < 0.05 relative to 
Novel Odor, one-way ANOVA with Tukey post hoc test.  Scale bar = 50µm. 
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 Given that both the odorant mixture and anesthesia alone activate c-Fos largely in 
neurons, we next addressed whether the neural sub-type was differentially affected in these 
groups.  Specifically, we were interested whether the odorant mixture activated a different ratio 
of excitatory and inhibitory neurons relative to anesthesia.  We therefore double-labeled sections 
from groups AIR-SNT (A1), AIR-SNT(Anes) (A2) and AIR-AIR(Anes) (A4) in experiment ‘A’ 
with antibodies against c-Fos and GAD67, a marker of inhibitory neurons.  Across all groups, we 
found relatively few c-Fos/GAD67 double-labeled cells in the anterior piriform cortex (overall 
AVG = 3.2% ± 0.3 of c-Fos+ cells).  Slightly greater co-labeling was found in the orbitofrontal 
cortex (overall AVG = 7.6% ± 0.5 of c-Fos+ cells).  A significant group effect (one-way 
ANOVA) was found in both the APC (F(2,19) = 5.47; p < 0.05) and OFC (F(2,18) = 5.71; p < 0.05).  
Tukey post-hoc test of the APC revealed a significantly greater percentage of double-labeled 
cells in the rats who received anesthesia alone (AIR-AIR(Anes), A4; Fig. 2-10) relative to those 
that received the odorant mixture alone (AIR-SNT, A1; p < 0.05).  Interestingly, in the OFC, we 
found significantly fewer double-labeled cells in the anesthesia alone group (AIR-AIR(Anes), 
A4) versus the odorant mixture alone group (AIR-SNT, A1; p < 0.05).  This suggests that the 






 Figure 2-10.  Overlay of c-Fos and GAD67 expression in the APC and OFC. 
Fluorescent micrographs of c-Fos(red)/GAD67(green)/DAPI(blue) triple-labeling in the APC (A) and OFC (B).  
Double-labeled c-Fos/GAD67 cells are represented as a percentage of the total density of c-Fos+ cells in the APC (C) 
and OFC (D).  Group percentages from (C) and (D) are replotted in (E) and (F), respectively.  Arrows indicate 
triple-labeled cells.  Data from experiment ‘A’.  (*) p < 0.05 relative to Novel Odor group, one-way ANOVA with 





In our behavioral work we found that rats exposed to a novel odorant mixture while anesthetized 
on the training day produced a robust behavioral response to the same odorant mixture on the test 
day (Fig. 2-2).  This response was indistinguishable from that of a novel odorant mixture.  This 
suggests that olfactory memory could not be retrieved for events occurring under general 
anesthesia.  These data are in line with a large body of literature showing profound multi-modal 
memory deficits resulting from anesthesia exposure (Weinberger et al., 1984; Ghoneim and 
Block, 1992; Pang et al., 1993; el-Zahaby et al., 1994; Alkire and Gorski, 2004; Bekinschtein et 
al., 2009).  There are, however, some reports of a memory enhancing effect of very low-dose 
halothane and sevoflurane anesthesia (Alkire and Gorski, 2004; Alkire et al., 2005). 
Explicit (or declarative) memory can be sub-divided into episodic memory, the 
autobiographical memory associated with an individual’s personal experiences, and semantic 
memory, which is a general knowledge about the world unrelated to autobiographical 
experiences.  Another sub-type of explicit memory is recognition memory (Squire et al., 2007), 
which is the type of memory that was behaviorally assessed in this study.  Recognition memory 
is a type of long-term memory involved in determining whether a stimulus has been previously 
encountered.  Exposure to a familiar person, object or experience is thought to be compared with 
a previously stored representation thus producing a matching signal (Norman and O'Reilly, 
2003).  Recognition memory is sub-divided into two components: recollection and familiarity.  
Recollection is thought to involve the memory of specific details of a previously experienced 
event, whereas familiarity is merely the knowledge that an event was previously experienced 
without any contextual details of the learning event (Brown and Aggleton, 2001; Squire et al., 
2007).  In this study we are interested in olfactory recognition memory, specifically that of odor 
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familiarity as we are unable to determine if further details of the odor experience are also 
present.  In rodents, olfactory recognition memory is critically important as conspecific odors are 
thought to be the primary means of identification, similar to face recognition in humans 
(Schaefer et al., 2001).  Furthermore, investigation into the underlying neurobiology of olfactory 
recognition memory has revealed the orbitofrontal cortex to be the critical region in mediating 
this process (Ramus and Eichenbaum, 2000). 
Despite a lack of behavioral recognition memory, a histological imprint was nevertheless 
formed of the olfactory events that occurred under anesthesia.  During general anesthesia, 
delivery of a novel odorant mixture activated c-Fos protein to a greater extent than anesthesia 
treatment alone (Fig. 2-5).   This pattern suggests that the olfactory events were registered 
despite anesthesia.  Not only was this information registered, but long-term changes appear to 
have occurred such that treatment with the same odorant mixture 24 hours later produced a 
‘familiar’, or attenuated, c-Fos histological response comparable to that seen in awake animals 
exposed to a repeated odorant mixture (Fig. 2-8).  Thus, the pattern of novel and familiar odorant 
exposure appeared similar in animals regardless of whether the odorants were experienced in the 
awake or anesthetized states.  These histological data, in combination with our behavioral data, 
suggest an interesting distinction between what information can be recalled following anesthesia 
and what information is actually stored.  In other words, a discrepancy may exist between what 
we know and what our brain knows regarding events that occurred during general anesthesia. 
Expression of c-Fos in the olfactory and olfactory-association cortices was elevated after 
the presentation of a novel odorant mixture while in the awake state (Fig. 2-3).  Our histological 
data showed repeated exposure to the same odorant mixture produced an attenuation of c-Fos 
expression in both the olfactory bulb and anterior piriform cortex.  For Egr1, presentation of the 
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odorant mixture elicited elevated protein expression; however, both novel and familiar odorants 
produced equally elevated Egr1 expression relative to naïve animals, indicating that Egr1 reflects 
the presence or absence of the odor stimulus.  Preferential expression of c-fos for novel (over 
familiar) stimuli mimics that found previously in the visual (Zhu et al., 1995; Zhu et al., 1996; 
Warburton et al., 2003), auditory (Kandiel et al., 1999; Wan et al., 2001), gustatory (Montag-
Sallaz et al., 1999) and olfactory (Brennan et al., 1992; Hess et al., 1995b; Montag-Sallaz and 
Buonviso, 2002) systems, thus suggesting a role in recognition memory.  However, expression of 
c-fos does not simply indicate novelty.  For example, an odor-reward association task activates c-
Fos in numerous odor processing regions but not when odorants and rewards are presented in an 
unpaired manner (Tronel and Sara, 2002). 
Egr1 and c-fos are immediate early genes that are both activity dependent, but have 
varying expression profiles (Guzowski et al., 2001).   It has been shown that egr1 closely reflects 
the pattern of synaptic events whereas c-fos expression does not (Wisden et al., 1990; Abraham 
et al., 1991; Abraham et al., 1993; Gjerstad et al., 2005).  While changes in synaptic strength (i.e. 
long-term potentiation; LTP) uniformly activate egr1 (Abraham et al., 1991), c-fos expression 
may only be turned on during long-lasting, as opposed to short-lived, LTP (Kaczmarek, 1992).  
The expression profile of egr1 has been shown to correlate with patterns of neural activity as 
demonstrated by 2-deoxyglucose (2-DG) labeling and optical imaging techniques (Inaki et al., 
2002).  As such, a number of studies have adopted the use of Egr1 as a marker of basic neural 
activity (Inaki et al., 2002; Mandairon et al., 2006b; Mandairon et al., 2008).  In contrast, direct 
electrical stimulation, which elicits olfactory bulb mitral cell activity, fails to induce c-fos 
expression (Montag-Sallaz and Montag, 2006).  Indeed, c-fos expression in the olfactory bulb 
has been shown not to parallel neural activity (Buonviso and Chaput, 1990; Sallaz and Jourdan, 
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1993), but to rely on top-down inputs as lesions to centrifugal afferents significantly reduce 
bulbar c-fos expression in response to odor.  These lesions, however, do not attenuate the bulbar 
2-DG response to the same odor (Sallaz and Jourdan, 1996).  In fact, patterns of c-fos expression 
differ from 2-DG labeling throughout the brain (Duncan et al., 1998).  Conversely, odorant 
stimulation of rodents with unilateral naris occlusion produces robust bulbar c-Fos expression 
both contralateral and ipsilateral to the occlusion (Jin et al., 1996).  Unilateral lesions of the locus 
coeruleus produces a widespread reduction of cortical c-Fos expression ipsilateral to the lesion 
without any change in the EEG signal (Cirelli et al., 1996).  As such, it is clear that c-fos 
expression encodes more than the activity state of the neuron.  In contrast, egr1 may more 
closely reflect the activity state of the neuron.   
There are also a number of similarities between c-Fos and Egr1 as both genes are 
regulatory transcription factors thought to be involved in learning and memory (Guzowski et al., 
2001; Guzowski, 2002).  It is therefore possible that the continued high levels of Egr1 with 
familiar odors is a result of reconsolidation, that is, the process by which consolidation 
mechanisms are reactivated during re-exposure to a learning cue (Sara, 2000; Sara and Hars, 
2006).  However, this is unlikely as we did not see continued high expression of c-Fos with 
familiar odors as well, which we would expect to see if reconsolidation mechanisms 
recapitulated initial consolidation.  Furthermore, the phenomenon of reconsolidation has been 
called into question as attempts to reproduce the original behavioral findings have failed 
(Dawson and McGaugh, 1969; Squire et al., 1976). 
If c-fos were to reflect memory consolidation, one would expect changes in c-Fos 
expression to occur in tandem with behavioral changes.  Previous work has shown that twenty 
minutes of odorant exposure for one week produces an attenuation in c-fos and arc 
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immunoreactivity to that odorant in the olfactory bulb (Montag-Sallaz and Buonviso, 2002), a 
finding that we have confirmed with c-Fos protein in various olfactory regions (Fig. 2-3, 2-8).  
However, we have found that it only takes a single 20 minute odorant exposure to produce a 
memory of the event 24 hours later (Fig. 2-4).  Investigation of the pattern of odor-induced IEG 
expression following a single previous exposure confirms that levels of c-Fos protein are also 
attenuated at this point, a pattern that mimics the behavioral profile.  As such, c-Fos is expressed 
in the appropriate temporal manner to reflect memory consolidation.   
Indeed, expression of c-fos is reported to be a critical component of the neural plasticity 
leading to memory formation (Rose, 1991; Kaczmarek, 1993).  Many studies have shown that c-
fos can reflect memory consolidation.  For example, infusion of the drug bicuculline into the 
accessory olfactory bulb, a process which has been shown to produce an artificial memory of 
male pheromones, also produces elevated c-fos expression (Brennan et al., 1992).  Additionally, 
treatments that disrupt memory of visual images also abolish corresponding c-fos expression 
(Warburton et al., 2003).  Noradrenergic fibers of the locus coeruleus descend into the olfactory 
bulb and provide a critical arousal component necessary for olfactory memories (Shea et al., 
2008).  Pharmacological inhibition of these noradrenergic afferents severely attenuates the bulbar 
c-fos expression in response to odors (Sallaz and Jourdan, 1996).   
Other studies indicate that c-fos may have a causative role in memory formation.  
Impaired long-term memory formation is observed during c-fos knockdown (Lamprecht and 
Dudai, 1996; Mileusnic et al., 1996; Grimm et al., 1997; Morrow et al., 1999) and in c-fos 
knockout mice (Paylor et al., 1994; Guzowski, 2002; Fleischmann et al., 2003).  Furthermore, 
memory impairments found in CNS-conditional c-fos knockouts are rescued when the c-fos gene 
is replaced by fra-1 (Fos-related antigen 1), a transcription factor of the same family (Gass et al., 
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2004).  These studies demonstrate a critical and proactive role of c-fos in the information 
consolidation of memory events, and not merely a reflection of neural activity.   
Knockdown of c-fos produced an impairment of a conditioned taste aversion memory.  
Interestingly, however, knockdown of egr1 in the same region had no effect (Yasoshima et al., 
2006).  As discussed previously, egr1 is expressed routinely during changes in LTP whereas c-
fos requires long-lasting, robust LTP to be expressed (Abraham et al., 1991; Kaczmarek, 1992; 
Abraham et al., 1993).  Furthermore, c-fos demonstrates low basal expression, whereas egr1 is 
expressed at high basal levels (Terleph and Tremere, 2006).  These studies indicate that c-fos 
expression requires a higher threshold of activity than that of egr1.  The robust neural activity 
associated with memory formation is thus more likely to parallel changes in c-fos expression 
than egr1.  A functional connection between c-fos and memory processes may explain why c-fos 
appears to be necessary for conditioned taste aversion memory, whereas egr1 is not.  Such a 
conclusion is consistent with the hypothesis that c-Fos reflects memory consolidation whereas 
Egr1 more closely reflects neural activity. 
The aforementioned c-fos knockdown and knockout studies, in tandem with our current 
findings with c-Fos immunohistochemistry (Figures 2-5, 2-6 and 2-8), support the view that 
memory processes can occur in the anesthetized brain similar to how they occur in the awake 
brain.  We speculate that this anesthesia-resistant memory consolidation occurred despite a low 
activity state as revealed by Egr1 immunolabeling.  Further studies utilizing an 
electrophysiological or in vivo imaging approach would be required to confirm these 
observations.  In a well known study, a false crisis was staged while patients were fully 
anesthetized for dental surgery and although there was no post-operative recall of the event, 
patients were able to describe the events that occurred verbatim while later under hypnosis 
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(Levinson, 1965).  Similarly, amnesia of a memory event in mice caused by subanesthetic doses 
of propofol was shown to be reversed by pharmacological manipulation 30 minutes prior to a 
recall test (Pang et al., 1993).  These studies suggest a sub-conscious, but potentially accessible, 
memory trace formed during anesthesia.  Our data help to support and reconcile these curious 
findings.   
We have found that subtle differences exist between the subtypes of cells activated by the 
odorant mixture or by ketamine/xylazine anesthesia alone.  For both forms of stimuli, c-Fos 
appears to be activated primarily in neurons (Fig. 2-9).  Of the c-Fos+ neurons, relatively few 
neurons were found to be inhibitory in nature (3.2%) in the APC, whereas a slightly greater 
percentage of c-Fos positive neurons were inhibitory in the OFC (7.6%; Fig. 2-10).  
Interestingly, ketamine/xylazine anesthesia and the odorant mixture activated c-Fos in slightly 
different populations of cells.  In the APC, anesthesia alone activated c-Fos to a greater extent in 
inhibitory neurons than the odor stimuli, with the opposite found in the OFC.  When a novel 
odorant mixture is given to a rat after week-long anesthesia, c-Fos does not become activated 
(Fig. 2-13) suggests that the brain may process odor and anesthesia stimuli in a similar manner.  
However, the difference in neural sub-type activated suggests a unique pattern of c-Fos 
activation for each stimulus.  To further clarify the sub-type of neurons activated by the odorants 
or anesthesia, future studies may want to address potential differences in the morphology, 
distribution or connections with noradrenergic, dopaminergic or cholinergic signaling pathways. 
We found an attenuated c-Fos response with repeated odorant administration in the APC 
and OFC in experiment ‘B’, but not in experiment ‘A’ (Fig. 2-4).  This discrepancy likely results 
from the difference between seven days of repeated exposure (Exp. ‘A’) and only a single repeat 
exposure (Exp. ‘B’).  Both the anterior piriform and orbitofrontal cortices encode a moderate to 
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high amount of associative content (Roesch et al., 2007).  It is therefore possible that 
compensatory mechanisms caused gradual changes in c-Fos expression, over the course of the 
week, to reflect this increasingly common element in the animal’s environment.   
Upon closer examination of our raw histological images (Fig. 2-5, 2-6) a greater intensity 
of antibody labeling was seen in animals receiving a novel odorant mixture during anesthesia 
than animals receiving a novel odorant mixture alone.  This finding is in line with a previous in 
vivo electrophysiological study which has revealed that odors elicit a stronger signal-to-noise 
neural response, in mouse olfactory bulb mitral cells, while under ketamine/xylazine anesthesia 
than while awake (Rinberg et al., 2006).  Future studies may want to address the significance of 
these findings. 
In experiment ‘A’ we maintained the body temperatures of our rats between 36-38ºC to 
prevent hypothermia.  A similar procedure was utilized in experiment ‘B’, though body 
temperature was inferred based on techniques used in experiment ‘A’.  The avoidance of 
hypothermia in our animals was important as it has previously been shown that hypothermia, 
produced by general anesthesia in the rodent (body temperatures between 26-30ºC), can lead to 
tau hyperphosphorylation, which was attributed to decreased protein phosphatase 2A (PP2A) 
activity (Planel et al., 2007).  Restoring normal body temperature in these animals prevented the 
associated changes in tau phosphorylation and PP2A activity.  In a related paper, it was shown 
that inhibited PP2A activity upregulated the transcription of a luciferase gene driven by the c-fos 
promoter (Johannessen et al., 2003).  Taken together, these papers suggest a role of anesthesia-
induced hypothermia in enhanced c-fos expression.  Other physiological endpoints (e.g. blood 
gases, heart rate, respiration rate, etc.) were not directly quantified in these studies.  The use of 
additional physiological monitoring devices was avoided to minimize the premature spread of 
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our novel olfactory cues (which may adhere to these devices) and to maintain the integrity of the 
odor-deprived environment.  Though we did not directly quantify measures of respiration 
quality, these variables may also have a significant impact on IEG expression as hypoxia and 
elevated CO2 (hypercapnia) are able to induce c-fos expression in various brain regions (Larnicol 
et al., 1994; Miura et al., 1994; Prabhakar et al., 1995; Haxhiu et al., 1996) including the piriform 
cortex (Dell'Anna et al., 1995).  This is thought to occur by causing elevated Ca2+ entry through 
L-type voltage-gated calcium channels (Premkumar et al., 2000).  However, based on related 
studies in our lab it was found that the color of the rat’s skin tone could reasonably predict the 
oxygen saturation of the blood, with a pink tone producing greater than 90% SpO2 (oxygen 
saturation; unpublished observation).  We used this as an indirect measure of respiration quality 
and did not observe any incidents of insufficient respiration in experiments ‘A’ or ‘B’.  We 
recognize that administration of the anesthetic alone may alter the physiological state of the 
organism; however, invasive measures of physiological parameters could introduce other 
confounding variables to our analysis.  Thus, to address the potential effects of the anesthetic on 
physiological measures and ultimately IEGs we ran control groups utilizing the anesthetic alone 
in both experiments ‘A’ and ‘B’ (groups AIR–AIR(Anes), A4, and AIR(Anes)–SNT, B4, 
respectively) to account for any effects of the anesthetic itself. 
We did not find a significant effect between anesthetized animals receiving the odorants 
and those not receiving the odorants in the primary region of olfactory processing: the olfactory 
bulb (Fig. 2-7).  It is well documented that ketamine anesthesia, and other NMDA antagonists, 
augment c-fos expression in various regions of the brain (Wilson et al., 1996; Duncan et al., 
1998).  In our study, ketamine/xylazine anesthesia alone produced a c-Fos response equal to or 
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greater than that of a novel odorant mixture in the olfactory bulb, thus obscuring any cumulative 
effects in that region.   
Though there were no significant differences in anesthetic dose administered (one-way 
ANOVA followed by Tukey post hoc test), animals in the AIR-AIR(Anes) (A4) group received a 
slightly greater dose (170.8 mg/kg ketamine, 22.8 mg/kg xylazine) relative to AIR-SNT(Anes) 
(A2) animals (125.1 mg/kg ketamine, 16.7 mg/kg xylazine), though not significantly different (t-
test, p = 0.10).  It has been shown that greater doses of ketamine anesthesia correlate with greater 
c-Fos protein expression in cortical areas, including the orbital and piriform cortices (Duncan et 
al., 1998).  As such, we expect our findings in Figures 2-5 and 2-6 to be even more robust with 
an identical anesthetic dosage. 
Long-term memory formation can occur during anesthesia in some altered brain states.  It 
has been shown that exogenous epinephrine can enable pavlovian conditioning under general 
anesthesia without altering the depth of anesthesia (Weinberger et al., 1984; el-Zahaby et al., 
1994).  More recently, memory of an odorant was shown to form in the anesthetized mouse when 
the odorant was presented with concurrent locus coeruleus stimulation (Shea et al., 2008).  Sub-
anesthetic doses typically produce amnesia (Pang et al., 1993; O'Gorman et al., 1998; Pitsikas et 
al., 2008); however, under certain circumstances, such as basolateral amygdala lesions (Tomaz et 
al., 1992; Alkire et al., 2001; Alkire and Nathan, 2005) or co-administration of cognitive-
enhancing agents such as nefiracetam (O'Gorman et al., 1998), memories are still able to be 
formed.  In line with these previous studies, our current findings support the notion that the brain 
may receive and retain information despite general anesthesia.  Some degree of information 
consolidation may occur, even if there is no evidence of memory recall.  This suggests that 
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anesthetic-induced amnesia may result from a deficit in retrieval or that initial consolidation 
mechanisms that do occur are incomplete.   
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3.0  CHARACTERISTICS OF BEHAVIORAL RECALL FOLLOWING 
ANESTHESIA 
3.1 INTRODUCTION 
Amnesia is one of the most profound effects of general anesthesia and even subanesthetic doses 
have been shown to produce profound memory loss (Block et al., 1988; Chortkoff et al., 1995; 
Imre et al., 2006).  However, the assumption that memories are completely blocked may not be 
entirely correct.  Growing evidence supports a view that initial memory consolidation may occur, 
and, under certain circumstances, can be recalled (Ghoneim and Block, 1992; Pang et al., 1993).  
Our initial tests on explicit olfactory memory revealed no evidence of memory for odorants 
presented during ketamine/xylazine general anesthesia.  Although a clearly defined explicit 
memory was not apparent, we hypothesize that, based on histological changes in various brain 
regions under anesthesia, behavioral endpoints can still reveal some element of familiarity.  
These may be evident through subtle behavioral or autonomic processes and may occur contrary 
to what is explicitly displayed by the animals.  We therefore studied whether an odorant, 
presented to animals under anesthesia, was reported as equally ‘novel’ as a completely novel 
odorant when the two were presented side-by-side.  We wanted to test whether any subtle 
preference was present for the completely novel odorant.  The test involved a discrimination task 
 58 
where odorized wooden beads were placed side-by-side in the animal’s home cage (Spinetta et 
al., 2008), and relative odor investigation time by the rodent was assessed. 
Disruption of the consolidation processes following a memory event can prevent recall of 
the particular memory (Sara and Hars, 2006).  These experimentally-induced amnesias can be 
produced through a number of methods including: anesthesia, electroconvulsive shock, carbon 
dioxide, hypothermia, disruption of neurotransmitter signaling and certain antibiotics and protein 
synthesis inhibitors (Flexner et al., 1963; Rigter and Van Riezen, 1979; Quartermain et al., 1988; 
Sara and Hars, 2006).  It is possible to reverse some experimentally-induced amnesias by 
treatment with nootropic (cognitive-enhancing) or psychostimulant drugs prior to memory tests 
(Quartermain et al., 1988; Quartermain and Leo, 1988).  These studies suggest that memory 
formation can occur despite the induction of amnesia.  To date, the potential for memory 
consolidation and pharmacologically-induced retrieval has not been addressed in animals 
anesthetized at surgical doses.  Thus, we also tested whether an anesthesia-paired memory could 
be re-elicited by pharmacological means. 
In rodents, the racetam class of nootropic drugs has been found to be effective at 
enhancing memory retrieval, combating amnestic agents and reversing experimentally-induced 
amnesias (Sara and Lefevre, 1972; Sara and David-Remacle, 1974; Franklin et al., 1986) 
including anesthetic-induced retrograde amnesia (O'Gorman et al., 1998).  The racetam class of 
drugs includes piracetam, nefiracetam, etiracetam, and pramiracetam and is thought to enhance 
cognitive function, in part, by working as allosteric modulators of the α-amino-3-hydroxy-5-
methyl-4-isoxazole propionic acid (AMPA) receptor (Ahmed and Oswald, 2010).  Piracetam is 
prescribed in humans for a variety of issues including cognitive disorders, dementia and dyslexia 
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(Winblad, 2005), and has been shown to boost memory function in healthy adults (Dimond and 
Brouwers, 1976).   
Another cognitive-enhancing agent, amphetamine, has been shown to reverse amnesia 
induced by low dose anesthesia (Pang et al., 1993) as well as amnesia induced by 
electroconvulsive shock, protein synthesis inhibition or modulation of cholinergic, noradrenergic 
or serotonergic systems (Quartermain et al., 1988; Quartermain and Leo, 1988).  Amphetamine 
is a psychostimulant that acts on the dopamine transporter (DAT) to increase synaptic dopamine 
and inhibit reuptake in the mesolimbic dopamine system (Leshner and Koob, 1999; Fleckenstein 
et al., 2007).  Historically, amphetamine is known for its use by World War II pilots and 
commercial truck drivers to enhance cognitive function and alertness.  Today, amphetamine 
derivatives are prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) 
but are also commonly misused by college students as a study aid (Kollins, 2008).  Several other 
pharmacological agents have also been shown to be effective at reversing amnesia including 
strychnine (Sara and Remacle, 1977), arecoline (Quartermain and Leo, 1988) and pituitary 
hormones (Rigter and Van Riezen, 1979).  To assess whether memories of olfactory events 
possibly registered under general anesthesia could be retrieved, we treated animals with various 
cognitive-enhancing drugs and looked for any signs of intact memory formation.   
In our current study we found that side-by-side comparison and pharmacological 
manipulation were unable to reveal any evidence of memory formation during ketamine/xylazine 
anesthesia, as determined by odor investigation time.  Interesting effects in approach latency, 
however, suggested a potential implicit or visceral/autonomic memory. 
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3.2 MATERIALS AND METHODS 
3.2.1 Experimental Animals 
For all experiments, 7-week old male Sprague Dawley rats were purchased from Harlan 
Laboratories (Indianapolis, IN).  Animals were maintained in a temperature (20-22ºC) and 
humidity controlled environment with a constant 12:12 light-dark cycle (on 07:00 - 19:00 hr).  
Animals were individually housed to prevent incidental odors and allowed one week to acclimate 
to the colony and odor environment prior to treatment.  The environmental odors in the housing 
facility were also strictly controlled to minimize any variation.  Food and water were available 
ad libitum.  All experimental protocols were approved by the Institutional Animal Care and Use 
Committee at the University of Pittsburgh. 
3.2.2 Experiment C:  Odor Discrimination Task 
Table 3-1.  Group Layout:  Experiment ‘C’  
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+ Bn or Ci 
Amphetamine 12 
     Total = 93 
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3.2.2.1 Procedure 
We adapted a previously described task (O'Dell et al.; Spinetta et al., 2008) for use with arbitrary 
odorants.  Rats received various treatments according to Table 3-1.  A total of 93 animals were 
used for this task.  One week after arriving in the colony, rats began a 24-hour familiarization 
period.  Each rat was handled for approximately 2 minutes, after which 4 round wooden beads 
were introduced into their home cage (day 1).  Wooden beads were 1-inch in diameter with a 
7/32” hole bore through the middle (Woodworks Ltd., Haltom City, TX) and individually coded 
with a black marker.  The beads remained in the home cage overnight to allow the animals to 
become familiar with the 4 control beads (Fig. 3-1).   The next morning (day 2), the beads were 
removed from the cage and the animal handled again for 2 minutes.   
Testing for odor preference or odor familiarity occurred later in the same day.  During the testing 
session the animal’s home cage was placed in a hard-ducted hood that vented directly to the 
exterior of the building.  Each animal was allowed to habituate to this environment for 10 
minutes.  Halfway through habituation, the lid of the cage was briefly removed and replaced to 
allow the ambient hood odors to fill the cage.  After habituation, the 4 familiarized control beads 
were returned to the cage in a manner similar to the testing procedure (see below).  The rats were 
allowed to freely interact with the control beads for five minutes, after which the beads were 
removed and the animal left alone for an additional 5 minutes.  Odor preference or recognition 
testing began following the 5 minute delay period.  The lid was removed and the animal was 
gently restricted to one end of the cage by hand.  Two of the control beads were placed back in 
the cage as well as two novel, scented beads.  The two novel beads were mildly scented with 
different odorants.  The four beads were placed in a row (Odorant A, Control, Control, Odorant 
B) on the far side of the cage approximately 1-inch from the cage wall (Fig. 3-1).  Each odorized 
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bead was placed on the far left or far right of two centrally positioned control beads to avoid 
ambiguity in the odor response.  The rat was then released and allowed to freely interact with the 
4 beads for 5 minutes.  A video camera was positioned outside the clear plastic cage to record the 
animal’s interaction with each bead.  The left-right position of each odorant was reversed 
between trials.   
Scented beads were produced by incubating wooden beads overnight in a 50ml Falcon 
tube (BD Biosciences, Bedford, MA) with 100 μl of odorant (diluted 1:10 in mineral oil) injected 
into a cotton reservoir in the bottom.  Four different odorants were used (obtained from Sigma, 
St. Louis, MO):  isoamyl acetate (banana, Bn), decanal (citrus, Ci), ethyl butyrate (berry, Be) and 
R-(-)-carvone (wintergreen, Wn; Table 3-1).  A plastic insert prevented beads from directly 
contacting the scented oil.  Any beads that came into direct contact with the oil were discarded.  
Pilot studies revealed that strongly scented beads were avoided or investigated from a distance.  
Our method produced beads with an odor that could barely be detected by the human nose.  Rats 
actively and directly investigated beads scented in this manner. 
Testing of odor preference was performed without any prior exposure to the specific 
odorants.  For tests of odor familiarity, animals were previously exposed to a specific odorant on 
day 1 (Table 3-1).  Pre-exposure of animals in the Awake condition occurred in a clean, empty 
cage within the hard-ducted hood.  After acclimating to this environment for 5 minutes, two 
tubes of undiluted odorant (35μl in Eppendorf tube) were introduced into the cage in opposite 
corners and the animal allowed to interact with the odor for 20 minutes.  The lid and odorant-
filled tubes were then removed and the animal was allowed to air off in the hood for 15 minutes 
to whisk away lingering odors.  Rats that were anesthetized then exposed to odorants received 10 
seconds  of  potent  exposure  (tube 1” from snout)  in  the  beginning, middle and end of  the  20  
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 Figure 3-1.  Simplified schematic of the odor discrimination task 
Four unscented beads were placed in rat’s home cage overnight to allow familiarization (Top).  Beads were removed 
in the morning for several hours (Middle).  Two beads scented with different odorants (typically banana and citrus; 
see section 3.3.1) and two unscented beads were reintroduced during testing (Bottom).  Test behavior was video 
recorded and percentage of time smelling each bead was assessed.  All procedure took place within the rat’s home 




minute period, and received moderate exposure (tube ≥ 5” from snout) for the remainder of the 
time.  These animals were then placed on a heating pad within the hood and allowed to air off for 
15 minutes before being returned to their home cage. Hypothermia was prevented by the 
combined use of lamps and heating pads positioned above and below the animal, respectively, 
throughout the period of anesthesia.  Techniques established to maintain body temperature 
between 36-38ºC in experiment ‘A’ were utilized in experiment ‘C’; however, direct measure of 
body temperature was not assessed.   
3.2.2.2 Behavioral Analysis 
Videos acquired during the behavioral task were assessed by a blinded observer.  Duration of 
time spent smelling was assessed for the first 30 and 60 seconds after the animal approached 
each bead.  Latency to approach was also assessed and capped at 30 seconds.  Smelling 
behaviors (bead-directed sniffing, rearing) within 1-inch of the bead were positively scored.  
Time spent chewing, rolling or playing with each bead did not count towards smelling duration.  
Smelling duration over all beads was summed and investigation time of each bead was 
represented as a percentage of the total smelling time to normalize for innately shy or inquisitive 
animals.   
3.2.2.3 Cognitive-Enhancing Agents 
To aid in memory retrieval some groups were treated with cognitive enhancing agents as 
described in Table 3-1.  Either piracetam (40 mg/kg; Sigma, St. Louis, MO) or d-amphetamine 
(1 mg/kg; Sigma) were administered 30 minutes prior to the odor familiarity test phase.  These 
doses and times have been shown to be effective at enhancing memory retrieval (Franklin et al., 
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1986; Quartermain and Leo, 1988; Pang et al., 1993).  Piracetam and d-amphetamine were 
dissolved in sterile saline and administered through intraperitoneal injection. 
3.2.3 Experiment D:  Odor Attenuation Task 










D1 AIR & Awake AIR Awake Amp – 2mg/kg -
30 min 
SNT & Awake 4 
D2 AIR & Awake SNT Anes Amp – 2mg/kg -
30 min 
SNT & Awake 4 
D3 AIR & Awake AIR Awake Str – 1mg/kg -   
20 min 
SNT & Awake 6 
D4 AIR & Awake SNT Anes Str – 1mg/kg -   
20 min 
SNT & Awake (4) 1 
D5 AIR & Awake AIR Awake Nef – 10mg/kg – 
1 hour 
SNT & Awake 2 
D6 AIR & Awake AIR Awake Pir – 80mg/kg – 
30 min 
SNT & Awake 4 
D7 AIR & Awake SNT Anes Pir – 80mg/kg – 
30 min 
SNT & Awake 4 
D8 AIR & Awake AIR Anes* Str – 1mg/kg -   
20 min 
SNT & Awake 6 
D9 AIR & Awake SNT Anes* Str – 1mg/kg -   
20 min 
SNT & Awake (6) 4 
D10 AIR & Awake AIR Anes K/X – 3mg/kg & 
0.4 mg/kg –      
20 min 
SNT & Awake 3 
D11 AIR & Awake SNT Anes K/X – 3mg/kg & 
0.4 mg/kg –      
20 min 
SNT & Awake 3 
D12 AIR & Awake AIR Anes Amp – 1mg/kg -
30 min 
SNT & Awake 3 
D13 AIR & Awake SNT Anes Amp – 1mg/kg -
30 min 
SNT & Awake 3 
      Total = (52) 47 
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3.2.3.1 Procedure 
The procedures in experiment ‘D’ were performed as described in experiment ‘B’ with the 
exception that all groups received injection of a cognitive-enhancing agent prior to the odor 
familiarity test.  These experiments were conducted in the Rodent Behavioral Animal Core 
(RBAC) of the University of Pittsburgh.  Experiments occurred in the dark with red-light 
illumination.  A custom built 17x17” black Plexiglas floor was constructed to fit inside an open 
field activity monitor (model ENV-515, Med Associates, St. Albans, VT) of the same 
dimensions.  A removable black Plexiglas cartridge, 2” in diameter, was positioned in the center 
of the floor, the profile of which acted as the ‘odorant zone’.  A 0.8-cm (diameter) hole in the 
center of the cartridge allowed indirect access to the odorant mixture from the testing field.  The 
odorant mixture was contained in a 1.5-ml Eppendorf tube (Hauppauge, NY) that was positioned 
within the cartridge.  The cartridge lay flush to the floor such that the animal could only detect 
the central hole.  A clear Plexiglas lid was positioned over the chamber to contain odors and 
allow for video recording from above.  Groups of rats received experimental treatments and 
pharmacological agents as described in Table 3-2. A total of 52 animals were used for the 
experiment.  All animals not receiving intraperitoneal injection of anesthesia or a cognitive-
enhancing drug were given 0.3ml saline injection 30 min prior to any behavioral work.  Three 
animals in group D4 and two animals in group D9 were excluded from behavioral analysis due to 
seizure-like activity.  The total original number of animals in each group, including those 
removed from analysis, is indicated in parentheses in Table 3-2.  
Rats received a day of handling then three days of habituation in the chambers for twenty 
minutes each day.  Halfway through the habituation, the cartridge was removed, the tube 
replaced with a new empty tube, and the cartridge was re-inserted.  On training and testing days, 
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rats were first acclimated to the chamber with an empty tube in the cartridge for 15 minutes.  
After that, the cartridge was removed and the tube replaced with either an odorant-filled tube or a 
similar empty tube.  During this experimental phase the rat was allowed to freely explore for a 
period of 5 minutes.  The odorant mixture used during this period was diluted 1:1000 in mineral 
oil (Sigma-Aldrich, St. Louis, MO).  35 µl of the diluted odorant mixture was injected into a 
cotton reservoir at the bottom of the 1.5-ml Eppendorf tube.  The odorant mixture used included 
equal parts of 6 different odorants (obtained from Sigma, St. Louis, MO) and included:  isoamyl 
acetate, cineole, octanol, decanal, capronaldehyde, and R-(-)-carvone.  Odorant-filled tubes were 
prepared ahead of time and stored in an air-tight container.  Caution was used to prevent 
incidental premature odor exposure.   
After the 5 minute trial animals were briefly returned to their home cage.  They were then 
transferred to a clean, empty rat cage within a hard-ducted hood in a nearby room.  Two tubes of 
the undiluted odorant mixture, or two empty tubes were then placed in the cage to ensure potent 
odor exposure similar to that administered in experiment ‘A’.  The rat was allowed to freely 
interact with the tubes for 20 minutes, after which they were aired off in a separate cage for 15 
minutes before being returned to their home cages.   
Several hours prior to receiving anesthesia on the training day, rats in the ‘Anes’ group 
first received an additional day of habituation to the behavioral chamber to ensure equal 
familiarity with the other groups.  Later the animals were anesthetized and placed directly in an 
empty cage within the hard-ducted hood for exposure to undiluted odorants.  These animals 
received a pulsatile odor exposure to mimic odor exploration while awake.  Rats received 10 
seconds of potent exposure (tube 1” from snout) in the beginning, middle and end of the 20 
minute period, and received moderate exposure (tube ≥ 5” from snout) for the remainder of the 
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time.  No tubes were used for anesthetized rats in the ‘AIR’ condition; however, they were 
otherwise treated identically.  Anesthetized animals were then aired off for 15 minutes in the 
hood before being transferred back to their home cages.  Lamps and heating pads were utilized to 
warm the animal as described in experiment ‘A’; however, direct measure of body temperature 
was not assessed. 
3.2.3.2 Behavioral Analysis 
Video was acquired and analyzed using Limelight automated tracking software (v3.0; 
Actimetrics, Wilmette, IL) with black and white CCD cameras (Panasonic, Secaucus, NJ).  Nose, 
body and tail locations were tracked using the software, and time of the nose within the pre-
defined odorant zone was quantified automatically for the first 10 and 30 seconds from approach.  
The latency of rats to approach the odorant zone was assessed and capped at a maximum of 30 
seconds.  All animals in this experiment approached the odorant zone within the time allowed for 
the trial (5 minutes).   
3.2.3.3 Cognitive-Enhancing Agents 
Prior to testing on day 5, rats were administered pharmacological agents to aid in memory 
retrieval according to Table 3-2.  The pharmacological agents used included (Sigma, St. Louis, 
MO): d-amphetamine (Amp, 2 mg/kg, 30 minutes prior and 1mg/kg, 7 hours prior), strychnine 
(Str, 1mg/kg, 30 minutes prior), nefiracetam (Nef, 10mg/kg, 1 hour prior) or piracetam (Pir, 80 
mg/kg; 30 minutes prior).  We also utilized low dose ketamine/xylazine anesthesia (K/X, 3mg/kg 
& 0.4mg/kg, 20 minutes prior).  Comparable doses and times of drug administration have 
previously been shown to be effective at retrieval (Sara and David-Remacle, 1974; Sara and 
Remacle, 1977; Franklin et al., 1986; Quartermain et al., 1988; Quartermain and Leo, 1988; Pang 
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et al., 1993; O'Gorman et al., 1998; Yamada et al., 1999).  Each drug was dissolved in sterile 
saline and administered through intraperitoneal injection.   
3.2.4 Anesthesia 
To ensure a uniform physiological state, rats were deeply anesthetized until they reached a 
surgical depth of anesthesia.  ‘Surgical depth’ was defined as decreased respiration rate and 
depth, decreased muscle tone and absence of response to a noxious (repetitive toe pinch) 
stimulus.  The anesthetic used was intraperitoneal injection of ketamine (Ketaset, Fort Dodge, 
Fort Dodge, IA; 100mg/ml) and xylazine (Anased, Lloyd Laboratories, Shenandoah, IA; 
100mg/ml).  An initial dose of anesthesia was used to immobilize the animals and subsequent 
booster injections were given until the appropriate plane of anesthesia was reached.  During the 
training trial rats were given an average dose of 183.4 ± 4.9 mg/kg ketamine and 24.5 ± 0.7 
mg/kg xylazine over an approximate 30 minute period in experiment ‘C’ and 173.7 ± 3.9 mg/kg 
ketamine and 23.6 ± 0.5 mg/kg xylazine in experiment ‘D’.  No significant differences were 
found between group averages for anesthetic dose administered in either experiment.  Doses of 
ketamine and xylazine (± Standard Error, SE) by group for each trial in experiments C and D are 
represented in Table 3-3.   
Table 3-3.  Average dose of ketamine/xylazine anesthesia (mg/kg ketamine, xylazine ± S.E.). 
Group Train Group Train Group Train Group Train 
C3 180.5 ± 7.5, 
24.2 ± 1.0 
D2 167.5 ± 3.7, 
22.7 ± 0.6 
D8 185.0 ± 15.8, 
24.7 ± 2.0 
D11 148.8 ± 3.1, 
20.3 ± 0.5 
C4 173.6 ± 8.0, 
23.2 ± 1.1 
D4 177.0 ± 16.6, 
24.3 ± 2.3 
D9 182.2 ± 5.6, 
23.9 ± 0.8 
D12 173.4 ± 21.8, 
24.4 ± 3.0 
C5 199.1 ± 8.8, 
26.6 ± 1.2 
D7 172.2 ± 8.4, 
23.6 ± 1.4 
D10 174.8 ± 6.8, 
23.9 ± 1.2 
D13 164.3 ± 5.0, 
22.8 ± 0.6 
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3.2.5 Statistical Analysis 
One-way ANOVA was used to determine a significant overall difference followed by Tukey’s 
post hoc analysis for inter-group comparison.  A student’s t-test was used for experiments 
containing only two groups.  Values are described as group means ± standard error. For all analyses, 
differences were considered significant when p < 0.05. 
3.3 RESULTS 
3.3.1 Adaptation of the odor discrimination task for arbitrary odorants 
The odor discrimination task has previously been used to assess memory of conspecific rodents 
(O'Dell et al.; Spinetta et al., 2008).  In these cases, beads that were incubated overnight in the 
animal’s home cage were tested against beads that were incubated in the cages of various 
different rats.  To exclude the complications of pheromones and the complex behaviors and brain 
activity associated with social cues (Dessi-Fulgheri and Lupo, 1982; Popik et al., 1991; 
Bannerman et al., 2001), and to remain consistent with our previous experiments, we attempted 
to apply arbitrary odorants to the odor discrimination task (Experiment ‘C’; group C1).  We first 
set out to find a pair of odorants for which rats showed a comparable affinity.  The four odorants 
tested included: banana (Bn), citrus (Ci), wintergreen (Wn) and berry (Be).  All six possible 
combinations of the four odorants were assessed (Fig. 3-2).  The distribution of animals in each 
group evolved such that more animals were allocated to groups where the odor investigation time 




Figure 3-2.  Specific odor preferences in the odor discrimination task 
Relative odor investigation times between various pairs of arbitrary odorants.  Pairs of odorant-scented beads were 
compared alongside non-scented control beads (Left-Center and Right-Center beads).  Data from experiment ‘C’.  
(*) p < 0.05 relative to leftmost bead (i.e. versus paired odorant).  Smelling duration for each bead (within 1st minute 
of approach) represented as a percentage of the total smelling time for all four beads. 
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One-way ANOVA was used to assess the relative investigation time of all four beads 
(two scented, two unscented) for each odor combination.  Tukey test was used for post hoc 
comparison of the two scented beads.  Statistical data for each odor combination are represented 
in Table 3-4.  The banana-citrus (Bn-Ci) and banana-wintergreen (Bn-Wn) combinations 
appeared to be the most comparable (see Fig. 3-2).  We chose the banana-citrus combination for 
subsequent experiments as these appeared to be the two most favored odorants when paired 
against other odorants.  However, banana did appear to be slightly favored and considerable 
variability existed in each rodent’s odor preference.  As such, the role of banana and citrus 
odorants were counterbalanced between each animal.   
 
Table 3-4.  Odor preference statistics 
One-Way ANOVA: 













p < 0.0001 p < 0.0001 p = 0.52 p = 0.10 p = 0.0001 p < 0.0001 
Tukey post hoc test between the two scented beads: 
p < 0.05 p = 0.33 p = 0.46 p = 0.21 p < 0.001 p < 0.001 
n = 12 n = 11 n = 2 n = 2 n = 2 n = 4 
 
We also assessed the spatial preference for each bead over all groups in experiment ‘C’ 
(Fig. 3-3).  Across all experiments, one-way ANOVA revealed a significant group effect (F(3, 376) 
= 139.3; p < 0.0001).  As expected, the left and rightmost positioned beads (odorized beads) 
were preferred over the center two control beads (non-odorized beads; p < 0.001 for all pair-wise 
comparisons).  However, tukey post-hoc test revealed no significant differences between left and 
rightmost odorized beads (p = 0.86, tukey posttest), or left-center and right-center non-odorized, 
control beads (p = 0.997).  This suggests that the spatial position of the beads during the task did 
not influence the rat’s smelling behavior. 
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 Figure 3-3.  No spatial preference in the odor discrimination task 
Relative odor investigation time as a function of bead location within cage.  Scented (Leftmost and Rightmost) 
beads were compared alongside non-scented control beads (Left-Center and Right-Center beads).  Spatial 
preferences were compiled over all groups in experiment ‘C’ (n = 95).  (*) p < 0.001 relative to leftmost and 
rightmost beads.  Smelling duration for each bead (within 1st minute of approach) represented as a percentage of the 
total smelling time for all four beads. 
 
3.3.2 Absence of anesthesia-paired memory in the odor discrimination task 
In order to validate the odor discrimination task using arbitrary odorants, we exposed rats to 
either a banana or citrus odorant on day 1.  On day 2, rats were presented with both banana and 
citrus scented beads as well as two unscented, control beads and odor familiarity was assessed 
based on relative odor investigation time (Experiment ‘C’; group C2).  Rodents will spend more 
time investigating a novel odor compared to a familiar odor (Mandairon et al., 2006a).  One-way 
ANOVA revealed a significant effect of smelling duration for all four beads (F(3,52) = 122.7; p < 
0.0001; Fig. 3-4A).  Tukey post-hoc test revealed that rats spent significantly more time 
investigating the bead scented with a novel odorant than the bead scented with the odorant that 
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was presented on the previous day (familiar odor; p < 0.001).  These results indicate that the odor 
discrimination task is a robust measure of odor familiarity even with arbitrary odorants, and that 
rodents display unequivocal familiarity with an odorant that was presented 24 hours previously. 
We then asked whether an odorant, delivered during ketamine/xylazine anesthesia, would 
be reported as equally novel as a completely novel odorant (group C3).  Rats were anesthetized 
and administered twenty minutes of either banana or citrus odorants, then tested with both 
odorants the following day.  One-way ANOVA indicated a significant effect across all beads 
(Fig. 3-4B; F(3,92) = 67.24; p < 0.0001).  However, no significant differences were found between 
the novel odorant and the anesthesia-paired odorant (p = 0.31, tukey posttest).  These data 
suggest that no memory of the anesthetic-paired odorant is evident in the odor discrimination 
task despite side-by-side comparison with a completely novel odorant. 
 
Figure 3-4.  Absence of familiarity for anesthesia-paired odorants in the odor discrimination task 
Odor investigation time between novel and familiar (A) or novel and anesthesia-paired (B) odorants relative to 
control, unscented beads (Left-Center and Right-Center).  Data from experiment ‘C’.  (*) p < 0.001 relative to Novel 
Odor bead.  Smelling duration for each bead (within 1st minute of approach) represented as a percentage of the total 
smelling time for all four beads. 
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 3.3.3 Screening of cognitive-enhancing pharmacological agents 
Many pharmacological agents have been labeled as cognitive-enhancing or nootropic drugs.  A 
number of these have been shown to ameliorate or reverse amnesia (Sara and Remacle, 1977; 
Franklin et al., 1986; Pang et al., 1993).  To date, the use of cognitive-enhancing agents to 
restore memories potentially acquired during surgical doses of general anesthesia has not fully 
been explored.  To assess the possibility of olfactory memory during anesthesia, rats were fully 
anesthetized with ketamine/xylazine anesthesia and given twenty minutes of exposure to the 
odorant mixture.  The following day rats were given an injection of a cognitive-enhancing agent 
then tested for familiarity with the odorants (Experiment ‘D’).  These rats were initially 
compared with rats also given the same drug prior to the test trial, but trained with ‘Air’ only.   
Table 3-5.  Statistical analysis of comparable drug treatments (student’s t-test) 
D1 vs D2 D3 vs D4 D5 D6 vs D7 D8 vs D9 D10 vs D11 D12 vs D13 
Amph Strych Nefir Piracetam Strych Ket/Xyl Amph 
p = 0.44 n/a n/a p = 0.51 p = 0.48 p = 0.70 p = 0.63 
 
We first tested amphetamine (2mg/kg) delivered 30 minutes prior to the familiarity test 
(Fig. 3-5A).  No significant differences (t-test, p = 0.44; Table 3-5) were found in the smelling 
durations of animals that were trained with air (group D1) and those trained with scent/anesthesia 
(D2); however, both groups paid little attention to the odorant stimulus and appeared hyperactive 
following amphetamine treatment.  Compared to novel scent (non-drug) controls from 
experiment ‘B’ (B2; open grey bar, Fig. 3-5A), odor investigation times for both groups treated 
with amphetamine (D1 and D2) were significantly attenuated (p < 0.05; student’s t-test).  We 
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concluded that doses of amphetamine (2mg/kg) that were best associated with memory retrieval 
(Quartermain and Leo, 1988) also impaired performance on the odor attenuation task.  We next 
tested strychnine (1mg/kg), administered 20 minutes prior to the familiarity test.  All six control 
strychnine animals (D3) performed adequately and were not significantly different than non-drug 
controls (B2 and B5).  However, rats that received scent/anesthesia (D4) during training 
displayed marked seizures in 3 of 4 animals, approximately 10-15 minutes following strychnine 
injection.  This indicated a potential interaction between strychnine, a glycine antagonist, and 
residual ketamine/xylazine anesthesia from the previous day.  As a result, we discontinued this 
group.  Two animals were given nefiracetam (10mg/kg) one hour prior to the test (D5); however, 
this group was discontinued due to solubility issues of nefiracetam in saline.  We next tested 
piracetam (80mg/kg) given 30 minutes prior to the familiarity test.  No significant differences 
were found between groups receiving piracetam treatment (D6 and D7; p = 0.51, t-test) even 
though both groups displayed a robust, ‘novel’ behavioral phenotype, similar to groups B2 and 
B5.   
Due to potential interactions of our cognitive enhancing drugs with residual anesthesia, as 
demonstrated by strychnine-induced seizure activity, we used animals trained with anesthesia 
alone as our control group for the remaining drug-treatments (Fig. 3-5B) to ensure that all groups 
were exposed to both the anesthetic and the cognitive-enhancing drug.  We again tested 
strychnine (1mg/kg) delivered 20 minutes before the odor test.  This time, rats were trained 2 
days prior to the test to reduce the residual anesthesia and possibility of seizures.  Only two of 
the 12 rats displayed any seizure-like activity (compared to 75% previously).  Of the remaining 
animals, no significant differences were found between rats trained with scent and anesthetic 
(group D9) or the anesthetic  alone  (D8) in  odor investigation time (t-test, p = 0.48),  suggesting  
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 Figure 3-5.  Effects of cognitive-enhancing drugs on memory retrieval 
Duration of odor investigation following treatment with various memory enhancing drugs.  Animals trained with 
scent while anesthetized were compared against animals trained with air alone (A) or air and anesthesia (B).  Dosage 
and timing (prior to testing) of drug received are indicated in parentheses.  Data from experiment ‘D’.  Smelling 
duration was measured for the first 30 seconds after approaching the odorant zone.  Amph = amphetamine, Ket/Xyl 
= ketamine/xylazine anesthesia. 
 
 78 
that strychnine was unable to reverse the anesthetic-induced amnesia.  To elucidate potential 
state-dependent effects, we treated animals with low-dose ketamine/xylazine anesthesia prior to 
the test to see if this might aid in memory retrieval; however, no significant differences were 
found between animals trained with scent/anesthesia (D11) or anesthesia alone (D10; p = 0.70, t-
test).  Lastly, we again tested amphetamine treatment; however, this time at a lower dose 
(1mg/kg) delivered 7 hours prior to the task.  No significant differences were found between 
groups (D12 and D13; p = 0.63, t-test) despite a robust behavioral response (absence of 
hyperactivity and distractibility).  These results suggested that none of the cognitive-enhancing 
agents tested were able to reverse anesthesia-induced amnesia in the odor attenuation task, as 
assessed by the duration of odor investigation. 
3.3.4 No effect of pharmacological manipulation on the odor discrimination task 
Though treatment of rats with cognitive-enhancing pharmacological agents was unable to reverse 
anesthetic-induced amnesia in the odor attenuation task (Fig. 3-5), it is possible that these agents 
may produce a more subtle effect only observable in the odor discrimination task (experiment 
‘C’).  We chose to utilize piracetam in the odor discrimination task (group C4) as this is a well 
documented memory-enhancing drug (Sara and David-Remacle, 1974; Franklin et al., 1986) that 
did not produce any confounding behavioral effects in the odor attenuation task.  We also found 
a possible effect in approach latency with this drug (see Section 3.3.5).  We compared the odor 
investigation time between an anesthetic-paired odor bead, a novel odor bead and two control 
(left-center and right-center) beads in rats pretreated with piracetam (40 mg/kg) 30 minutes 
before the test.  One-way ANOVA revealed a significant effect of investigation time across 
beads (F(3,44) = 20.98; p < 0.0001; Fig. 3-6A); however, pair-wise comparison of novel and 
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anesthetic-paired odorants revealed no significant differences in piracetam-treated animals (p = 
0.995; tukey posttest). 
 
 
Figure 3-6.  Effects of pharmacological manipulation on the odor discrimination task 
Smelling duration between novel and anesthesia-paired odorants for piracetam (A) and amphetamine (B) treated 
animals.  Piracetam (40mg/kg) and amphetamine (1mg/kg) were delivered 30 minutes prior to testing.  Data from 
experiment ‘C’.  Smelling duration for each bead (within 1st minute of approach) represented as a percentage of the 
total smelling time for all four beads. 
 
We also investigated the memory-enhancing capabilities of amphetamine in the odor 
discrimination task (group C5).  Amphetamine was used as it is also a well documented memory 
enhancer (Quartermain et al., 1988; Quartermain and Leo, 1988) that has specifically been 
shown to reverse anesthetic-induced amnesia (Pang et al., 1993).  We similarly compared the 
odor investigation time of each bead for rats administered amphetamine (1mg/kg) 30 minutes 
prior to the memory test.  We found a significant effect of investigation time over all beads 
(F(3,44) = 9.22; p < 0.0001; one-way ANOVA; Fig. 3-6B); however, we did not find a significant 
effect between novel and anesthetic-paired odorants (p = 0.97; tukey posttest).  These data 
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suggest that neither piracetam nor amphetamine treatment were able to restore explicit memory 
of anesthetized events as determined by odor investigation time. 
3.3.5 Possible memory of anesthesia-paired odorants through indirect measures 
Latency to approach the odor stimulus was assessed as a second and indirect measure of odor 
familiarity.  Analysis of approach latency in tandem with pharmacological manipulation 
produced some interesting results.  During our screening of pharmacological agents (experiment 
‘D’), we found a significant difference in the approach latency of piracetam-treated rats trained 
with scent/anesthesia (SNT(Anes)-SNT, group D7; Avg. = 23.4 s ± 4.1) and piracetam-treated 
rats trained with air alone (AIR-SNT, group D6, Avg. = 8.4 s ± 4.4; student’s t-test; p < 0.05; 
Fig. 3-7A).  These data suggest that piracetam treatment attenuated the urgency of odor 
investigation in rats previously exposed to the odorant while anesthetized; however, net odor 
investigation time remained unaffected.  No other significant latency effects were found for 
groups in experiment ‘D’.   
In the odor discrimination task (experiment ‘C’), we found a significant difference 
between groups (C2-C5) in latency to approach the first bead (Fig. 3-7B; F(3,57) = 2.79; p < 0.05; 
one-way ANOVA).  Post-hoc comparison revealed that rats trained with an odorant under 
anesthesia (Novel vs Anes-Paired, group C3) appeared to have longer approach latencies (Avg. = 
8.25 s ± 1.38) than rats trained with the odorants while awake (Novel vs Familiar, group C2; 
4.89 s ± 0.52); however, this effect was not significant (p = 0.15; tukey posttest).  Interestingly, 
rats trained with an odorant under anesthesia, but pretreated with the cognitive-enhancing agents 
piracetam (Novel vs Anes-Paired (PIR), group C4) or amphetamine (Novel vs Anes-Paired 
(AMPH), group C5) prior to the test displayed similar approach latencies (4.55 s ± 0.86 and 4.80 
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s ± 0.78, respectively) to rats trained without anesthesia (C2 vs C4: p = 0.998; C2 vs C5: p = 
1.00; tukey posttest).  However the reduction in approach latency for rats pretreated with 
memory enhancing drugs did not reach significance (C3 vs C4: p = 0.12; C3 vs C5: p = 0.16; 
tukey posttest).  These findings suggest a potential indirect memory of the anesthesia-paired 
odorants produced by the administration of either piracetam or amphetamine.   
 
 
Figure 3-7.  Latency effects in experiments ‘C’ and ‘D’ 
Approach latency between rats treated with piracetam and tested with novel or anesthesia-paired odorants in the 
odor attenuation task (A).  Differences in approach latency for groups in the odor discrimination task (B).  Data from 
experiments ‘C’ and ‘D’.  (*) p < 0.05 relative to Air-SNT group.  PIR = piracetam; AMPH = amphetamine. 
 
It should be noted that approach latency in the odor attenuation task was highly variable 
and did not appear to be a robust measure of odor familiarity.  No significant effects were found 
for approach latency in experiments ‘A’ or ‘B’.  Although, the number of animals in experiments 
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‘A’ and ‘B’ was lower (odor attenuation task; n = 6-7) than that in experiment ‘C’ (odor 
discrimination task; n = 12-24), which may contribute to the greater variability. 
3.4 DISCUSSION 
In the odor discrimination task, rats were forced to choose between a completely novel and an 
anesthetic-paired odorant.  This allowed us to test whether anesthetic-paired odorants, reported 
as ‘novel’ in the odor attenuation task, were reported as equally interesting relative to a 
completely novel odorant.  The side-by-side nature of both odorants in the odor discrimination 
task allowed us to tease apart more subtle distinctions than that found in the odor attenuation 
task.  We validated that memory formation could occur with arbitrary odorants in the odor 
discrimination task; however, we did not find any evidence of explicit memory for events 
occurring under anesthesia.   
Subanesthetic doses of general anesthesia can produce experimentally-induced amnesia, a 
type of memory loss that can be reversed by treatment with cognitive enhancing agents (Pang et 
al., 1993; O'Gorman et al., 1998).  We therefore screened a number of cognitive-enhancing 
agents, using the odor attenuation task, to assess their potential memory enhancing effects for 
events occurring under surgical doses of general anesthesia.  We found no differences between 
the odor investigation times of novel and anesthetic-paired odorants for all pharmacological 
agents tested.  However, animals pretreated with piracetam appeared less eager to approach an 
odorant mixture if it was previously delivered to the animal under anesthesia.  Once the odorant 
mixture was approached, however, rats spent an equal amount of time investigating the 
anesthesia-paired odorant mixture as they would a novel odorant mixture.   
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Based on our initial screening of cognitive-enhancing agents, we utilized piracetam and 
amphetamine (though no effects were found for this drug) in conjunction with the odor 
discrimination task in hopes that the memory-enhancing drugs would facilitate retrieval when 
novel and anesthetic-paired odorants were presented side-by-side.  Treatment with either agent 
had no effect on the relative investigation time of novel and anesthetic-paired odorants.  Both 
odorants were reported as equally ‘novel’ for each treatment, thus indicating no memory of the 
odorant administered during anesthesia.  However, both piracetam and amphetamine appeared to 
normalize approach latency to that found in non-anesthetized animals, a finding that may reflect 
some level of odor recognition.   
One interpretation of the effects on approach latency in the odor discrimination task (Fig. 
3-7) is that the presentation of both anesthesia-paired and completely novel odorants produces an 
indecisive behavioral phenotype in the rat.  The animal may have difficulty choosing the 
appropriate odorant to approach as both odorants seem to be ‘novel’.  Previous exposure to the 
odorant while in the awake state appears to clarify this ambiguity and the animal readily 
approaches the odorants.  Similarly, pretreatment with cognitive enhancers, in animals trained 
with scent/anesthesia, also reconciles the ambiguity.  In this case, now the animal ‘knows’ that 
the odorants are either novel or familiar.  Regardless, these data reveal a potential memory trace 
not be evident in our tests of explicit olfactory memory (odor investigation time).  This supports 
the hypothesis that some level of consolidation occurred in these animals.  It is unknown, 
however, whether explicit memory was absent due to incomplete information consolidation or a 
deficit in memory retrieval. 
In contrast to the explicit odor recognition (familiarity) memory observed in animals 
previously exposed to the odorants while awake, the interesting latency effects in the odor 
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attenuation and odor discrimination tasks suggest a possible implicit or visceral/autonomic 
familiarity response to an anesthetic-paired odorant.  An “implicit” memory may best describe 
our observed effects as task latency has previously been used as a measure of implicit memory in 
mice (Trueman et al., 2005).  Furthermore, latency effects appeared to occur in our study in the 
absence of conscious recall, which further suggests a role in implicit memory.  It is nonetheless 
possible that effects seen with latency actually utilize neuronal processes and pathways distinct 
from “implicit” memory.  Human studies have revealed that novel and familiar odors can 
produce unique physiological responses.  Specifically, repeated odorant administration produces 
autonomic changes in facial electromyography, heart rate and abdominal respiratory amplitude 
(Delplanque et al., 2009).  To date, the use of these autonomic functions as a measure of 
anesthesia-resistant memory has not been assessed, but provides direction for future study.  
Previous clinical studies have indicated that some implicit memory formation may occur during 
anesthesia (Block et al., 1988; Iselin-Chaves et al., 2005).  In one study, patients were fully 
anesthetized with propofol, after which the dose was briefly lowered and individuals were 
allowed to return to a verbally responsive state.  The patients were then presented with a picture, 
a sound and an odorant and re-anesthetized.  Though explicit memory was later absent in all 
patients, approximately a third of the patients reported “… vague sensations, one of a colour, one 
of a smell and one of a sound (Barr et al., 2001).”  These reports seem to echo that found in the 
blindsight literature, where patients describe an astoundingly accurate ‘feeling’ of an object’s 
appearance or movement, despite visual cortical defects that produce complete perceptual 
blindness (Weiskrantz et al., 1974; Cowey, 2010).  Interestingly, these blindsight patients also 
have intact neuroendocrine and reflexive responses when exposed to visual stimuli (Stoerig and 
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Cowey, 1997), a finding that further suggests a potential anesthesia-resistant memory in the form 
of intact visceral/autonomic functions. 
The use of strychnine has been shown to be effective at attenuating amnesia induced by 
electroconvulsive shock (Sara and Remacle, 1977).  We did not find any effects of strychnine on 
enhancing the retrieval of an anesthetic-paired odor memory (Fig. 3-5).  However, in order to 
avoid interactions between strychnine and ketamine/xylazine anesthesia, rats were trained two 
days prior to testing.  It is possible that simple olfactory recognition memory is no longer intact 
at 48 hours post-training and this produced a false negative result with strychnine treatment.  
This conclusion is unlikely given the lack of effects we found for the other cognitive-enhancing 
drugs.  Also, early pilot studies revealed odorant recognition present several days after the initial 
exposure (experimenter observation).   
An early study performed by an oral surgeon demonstrated that patients were unable to 
remember events that occurred during anesthesia; however, these memories were able to be 
retrieved later during hypnosis (Levinson, 1965).  This suggests a potential state-dependent 
retrieval effect.  We chose to test this by using a subanesthetic dose of ketamine/xylazine 
(3mg/kg and 0.4mg/kg, respectively), in attempt to induce state-dependent effects.  This dose 
was shown to affect memory processes without altering task performance (Pitsikas et al., 2008).  
At this dose, our animals performed the task adequately; however, no memory of the anesthetic-
paired odorant mixture was elicited.  It is therefore possible that state-dependent retrieval does 
not occur with ketamine/xylazine anesthesia.  Alternatively, the low dose anesthesia used may 
not have been sufficient to recreate the state under which the memory would have been acquired.  
Indeed, a dichotomy exists between subanesthetic and fully anesthetic doses of ketamine in brain 
activity and autonomic response (Duncan et al., 1998; Langsjo et al., 2005), suggesting that the 
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retrieval state may not have reflected the acquisition state.  As such, it is possible that a state-
dependent retrieval effect may still be observed at higher anesthetic doses than that which was 
utilized in this experiment. 
Using the pharmacological agents piracetam, amphetamine and strychnine, we were 
unable to find evidence of explicit memory retrieval following anesthesia.  Other agents have 
shown promise in reversing amnesia and alleviating memory deficits including nefiracetam 
(O'Gorman et al., 1998; Yamada et al., 1999), pituitary hormones (Rigter and Van Riezen, 1979), 
GSK189254 (Foley et al., 2009), and arecoline (Quartermain and Leo, 1988).  Epinephrine 
(Weinberger et al., 1984) and norepinephrine (Shea et al., 2008) have been shown to facilitate 
memory formation under general anesthesia and may also enhance subsequent retrieval.  Future 
studies could address the potential for these agents to restore memories of anesthetic-paired 
events.  We did find some level of initial information consolidation with piracetam and 
amphetamine as evident by subtle effects in approach latency.  These data provide interesting 
evidence that information received during anesthesia can be reflected in subsequent behavior. 
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4.0  SPECIFICITY OF HISTOLOGICAL CONSOLIDATION 
4.1 INTRODUCTION 
In chapter 2 we found that administration of a novel odorant mixture during ketamine/xylazine 
anesthesia caused an activation of c-Fos protein similar to that which occurred in awake animals.  
This may indicate that certain mechanisms of memory consolidation are activated during 
anesthetic-induced unconsciousness.  It is unknown whether this effect is specific to 
ketamine/xylazine anesthesia or is a universal trait amongst anesthetics.  To address the ubiquity 
of ketamine/xylazine effects, potential histological consolidation was assessed with pentobarbital 
and propofol anesthesia.  Pentobarbital and propofol are ideal anesthetics as both these drugs 
differ in their proposed mechanisms of action from ketamine, which primarily acts through 
inhibition of the N-Methyl-D-aspartic acid (NMDA) receptor (Harrison and Simmonds, 1985; 
Martin and Lodge, 1985).  Pentobarbital is a barbiturate anesthetic commonly used in veterinary 
medicine, that has strong effects on the γ-aminobutyric acid type A (GABAA), nicotinic 
acetylcholine (nACh), α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and 
kainate receptors with no effect on NMDA receptors (Carla and Moroni, 1992; Pistis et al., 1997; 
Krasowski and Harrison, 1999).  Propofol is an anesthetic frequently used in humans for 
anesthesia induction, maintenance and sedation, which potently modulates the GABAA and 
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glycine receptors with little effect on NMDA receptors (Hales and Lambert, 1991; Pistis et al., 
1997; Rudolph and Antkowiak, 2004). 
The direct modulation of c-Fos expression in olfactory regions by the anesthetic agent 
itself is undesirable.  This is one of the major caveats with ketamine anesthesia (Duncan et al., 
1998).  Pentobarbital is reported to cause minimal c-Fos activation in most brain regions (Marota 
et al., 1992; Takayama et al., 1994), whereas propofol has produced mixed findings (Nagata et 
al., 1998; Kidambi et al., 2010).  The effect of these drugs on c-Fos expression within olfactory 
regions is not well characterized. 
We also wanted to determine whether complimentary evidence of information 
consolidation could be revealed by other types of histological changes.  Modulation of  Neural 
Cell Adhesion Molecule  (NCAM) polysialylation is thought to play a major role in the synaptic 
restructuring necessary for memory consolidation (Schachner, 1997).  NCAM is a glycoprotein 
involved in cell-cell adhesion, neurite outgrowth, neurogenesis and synaptic plasticity (Durbec 
and Cremer, 2001; Bonfanti, 2006).  Earlier studies have shown that memory acquisition leads to 
an increased expression of synaptic membrane glycoproteins (Rose, 1995b, a), and blocking 
glycoprotein synthesis by intracranial injection of 2-deoxygalactose produces task-specific 
amnesia (Scholey et al., 1993).  Similarly, intracranial injection of an anti-NCAM antibody at 6 
hours post-training produces amnesia for passive avoidance (Scholey et al., 1993; Alexinsky et 
al., 1997) and odor-reward association tasks (Roullet et al., 1997).   
Memory acquisition has been shown to involve a transient increase in hippocampal PSA-
NCAM, specifically at 12 hours post-training in numerous tasks including odor-reward 
association (Foley et al., 2003), passive avoidance (Doyle et al., 1992; Fox et al., 1995), spatial 
learning (Murphy et al., 1996) and fear conditioning tasks (Sandi et al., 2003).  These effects 
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occur within the neurogenic region of the hippocampus; however, they are reported to function 
independently of changes in neurogenesis (Fox et al., 1995; Foley et al., 2008).  Drugs that 
produce memory-enhancing effects have also been shown to augment NCAM polysialylation 
within the dentate gyrus (Murphy et al., 2006; Foley et al., 2008; Foley et al., 2009).  
Interestingly, anesthesia-induced amnesia prevents the transient increase in hippocampal PSA-
NCAM, yet nootropic drugs that reverse amnesia, also restore expression of PSA-NCAM 
(O'Gorman et al., 1998).  The diversity of tasks assessed and effects of memory-enhancing drugs 
suggest that PSA-NCAM may be a common mechanism of memory consolidation.   
The hippocampus, however, is not involved in simple olfactory recognition memory 
(Staubli et al., 1995; Bunsey and Eichenbaum, 1996) and odorant treatment alone has no effect 
on hippocampal PSA-NCAM (Foley et al., 2003).  The role of NCAM in memory consolidation 
outside of the hippocampus is not well understood.  PSA-NCAM-positive cells have been 
reported to occur within the piriform cortex and PSA-NCAM is proposed to play an important 
role in olfactory learning in this region (Knafo et al., 2005).  We therefore assessed whether odor 
recognition memory involves changes in PSA-NCAM expression by quantifying the PSA-
NCAM labeling within the APC and OFC 12 hours after presentation of a novel odorant mixture.  
We also assessed whether similar changes could occur under anesthesia and to what extent. 
Another potential means of information consolidation could be reflected through changes 
in the proliferation and survival rates of new adult-born neurons.  Neurogenesis continues to 
occur throughout adulthood in select regions of the vertebrate brain.  The subventricular zone is 
one of two undisputed neurogenic regions that gives rise to neural progenitor cells (Lois and 
Alvarez-Buylla, 1994; Gould, 2007).  These cells enter the rostral migratory stream (RMS) and 
travel to the olfactory bulb in the anterior-most part of the brain where the precursor cells can 
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differentiate into the interneurons of the glomerular and granule cell layers (Lledo et al., 2006).  
A number of these cells will integrate into the local circuitry of the bulb (Carlen et al., 2002; 
Carleton et al., 2003); however, a large percentage fail to establish appropriate connectivity and 
die off (Biebl et al., 2000; Petreanu and Alvarez-Buylla, 2002).  The subgranular zone of the 
hippocampus is another neurogenic region, although the progenitors in this region only migrate a 
short distance giving rise to the granule cells of the dentate gyrus (Ehninger and Kempermann, 
2008).  The process of adult neurogenesis is thought to occur in order to maintain and refine 
hippocampal and bulbar networks (Imayoshi et al., 2008). 
It has been shown that odor enrichment can produce enhanced olfactory bulb 
neurogenesis and improved olfactory memroy (Rosselli-Austin and Williams, 1990; Rochefort et 
al., 2002; Rochefort and Lledo, 2005).  We therefore wanted to determine if odorant exposure 
during periods of anesthesia was able to produce a similar enhancement of neurogenesis, that is, 
we wanted to assess whether conscious perception was required for odor-induced neurogenesis.  
We analyzed the proliferation and migration of newborn neurons by quantifying the number of 
PSA-NCAM-positive cells within the rostral migratory stream.  We also analyzed the survival of 
newborn neurons through BrdU (5-bromo-2'-deoxyuridine) labeling.  BrdU is an analogue of the 
nucleoside thymidine that is incorporated into dividing cells during S-phase, thus allowing one to 
label, quantify and track newborn neurons (del Rio and Soriano, 1989). 
Our current work suggests that consolidation in olfactory regions during anesthesia may 
not be a universal trait amongst all anesthetics; however, these data are not conclusive.  
Furthermore, previous findings of c-Fos-mediated consolidation during anesthesia are 
corroborated by changes in neurogenic proliferation, but not survival.  NCAM polysialylation in 
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olfactory-associated cortical regions was not augmented during the acquisition of odor 
recognition memories, thus the effects of anesthesia could not be determined. 
 
 
4.2 MATERIALS AND METHODS 
4.2.1 Experimental Animals 
For all experiments, 7-week old male Sprague Dawley rats were purchased from Harlan 
Laboratories (Indianapolis, IN).  Animals were maintained in a controlled temperature (20-22ºC) 
and humidity environment with a constant 12:12 light-dark cycle (on 07:00 - 19:00 hr).  Animals 
were individually housed to minimize incidental odors and allowed one week to acclimate to the 
colony and odor environment prior to treatment.  The environmental odors in the housing facility 
were also strictly controlled to minimize any variation.  Food and water were available ad 
libitum.  All experimental protocols were approved by the Institutional Animal Care and Use 






4.2.2 Preliminary Experiment:  Screening of Anesthetic Agents 
Table 4-1.  Doses of various anesthetics 




Pentobarbital 128.1 ± 10.8 5 
Etomidate 44.1 ± 3.0 2 
Fentanyl / 
Medetomidine 
0.329 ± 0.042 /  




138.4 ± 11.6 /  
18.45 ± 1.55 
3 
Fentanyl 0.410 ± 0.009 2 
Medetomidine 1.629 1 
Saline n/a 2 
  Total = 18 
 
Each rat was handled and given a saline injection (0.3ml) once a day for two days.  On the third 
day rats were anesthetized and sacrificed two hours after reaching a surgical depth of anesthesia 
(absence of response to repeated foot pinch).  The anesthetics tested were pentobarbital 
(Nembutal, Ovation Pharmaceuticals, Deerfield, IL), etomidate (Amidate, Hospira, Lake Forest, 
IL) and Fentanyl/Medetomidine (Fentanyl, Hospira, Lake Forest, IL / Domitor, Pfizer, New 
York, NY).  Ketamine (Ketaset, Fort Dodge, Fort Dodge, IA) and xylazine (Anased, Lloyd 
Laboratories, Shenandoah, IA) anesthesia was also used as a positive control.  Fentanyl alone 
and medetomidine alone were also tested, but did not produce robust anesthesia.  All anesthetics 
were delievered via intraperitoneal injection.  Doses for each group are listed in table 4-1.    
Lamps and heating pads were utilized to warm the animal as described in experiment ‘A’; 
however, direct measure of body temperature was not assessed.  An additional control group 
received only saline injection (1.3ml).  A total of 18 animals were used for anesthetic screening. 
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4.2.3 Experiment E:  Pentobarbital Anesthesia 






E1 Pentobarbital & Novel Odor 111.3 ± 1.8 9 
E2 Pentobarbital Alone 118.6 ± 9.6 (8) 5 
   Total = (17) 14 
 
Rats received one day of handling, then given a saline injection (0.3 ml, i.p.) for 4 days and 
handled in the hard-ducted hood where testing would take place to reduce c-Fos activation 
resulting from the injection or environmental factors.  On the test day, rats were fully 
anesthetized to a surgical depth with pentobarbital and placed in the hard-ducted hood for twenty 
minutes of odorant exposure.  A tube containing 35µl of the undiluted odorant mixture was 
placed approximately 1-inch from the snout in a typical rat cage during the exposure period, after 
which the tube was removed and the animal allowed to air off for 15 minutes.  The odorant 
mixture used was the same combination used in experiments ‘A’, ‘B’ and ‘D’.  It was composed 
of an equal mixture of 6 individual odorants (obtained from Sigma, St. Louis, MO):  isoamyl 
acetate, cineole, octanol, decanal, capronaldehyde, and R-(-)-carvone.  Animals were sacrificed 
by pentobarbital overdose 2 hours after exposure to the odorant mixture, or a comparable time 
point in non-exposed animals.  An average dose of 114.9 ± 3.0 mg/kg pentobarbital anesthesia 
was administered in experiment ‘E’ over an approximate 40 minute period.  There were no 
significant differences for anesthetic dose between groups (p = 0.34; student’s t-test; Table 4-2).  
Lamps and heating pads were utilized to warm the animal as described in experiment ‘A’; 
however, direct measure of body temperature was not assessed.  A total of 17 animals were used 
in this experiment.  Three animals in group E2 died prematurely due to anesthetic treatment. 
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4.2.4 Experiment F:  Propofol Anesthesia 







F1 Propofol & Novel Odor 436.4 ± 14.3 (9) 8 
F2 Propofol Alone 428.0 ± 24.0 8 
   Total = (17) 16 
 
In experiment ‘F’, rats received one day of handling and 3 days of saline injections (0.3 ml, i.p.) 
prior to the test day.  During testing, rats were given an initial dose of 200 mg/kg propofol 
(Propoflo; Abbott Laboratories, North Chicago, IL) through intraperitoneal injection.  They were 
given a follow-up dose of 200 mg/kg after 35 minutes, and a small booster of variable size was 
given as necessary, to reach a surgical plane of anesthesia, after 70 minutes.  Rats receiving the 
odorants were exposed at 85-95 minutes following the initial propofol injection.  This dosing 
regimen was found to produce reliable and prolonged loss-of-righting-reflex via intraperitoneal 
route without the use of concomitant detergents.  Propofol is typically administered through 
intravenous injection; however, others have shown that intraperitoneal injection can produce 
robust anesthesia when administered at much higher doses (Irifune et al., 1999).  Rats received 
an average cumulative dose of 432.2 ± 13.5 mg/kg propofol over an approximate 90 minute 
period.  There were no significant differences in anesthetic dose between groups (p = 0.77; 
student’s t-test; Table 4-3).  Lamps and heating pads were utilized to warm the animal as 
described in experiment ‘A’; however, direct measure of body temperature was not assessed.  
The odorant mixture was delivered in a typical rat cage within a hard-ducted hood to control 
residual odors.  Two tubes of the undiluted odorant mixture (35µl/tube) were introduced into the 
rat cage.  The odorant mixture used was composed of an equal mixture of 6 individual odorants 
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(obtained from Sigma, St. Louis, MO): isoamyl acetate, cineole, octanol, decanal, 
capronaldehyde, and R-(-)-carvone.  Animals received twenty minutes of pulsatile odorant 
exposure to mimic natural odor exploration.  A tube was placed approximately 1 inch from the 
snout for ten seconds at the beginning, middle and end of the twenty minute exposure period.  
Both tubes were placed approximately 5 inches from the snout for the remainder of the time.  
Animals were sacrificed two hours after exposure to the odorant mixture or a comparable time-
point in animals not receiving the odorants. 
 
4.2.5 Experiment G:  PSA-NCAM 





Xylazine ± S.E.) 
n = 
G1 Novel Odor n/a 
 
8 
G2 Anesth. & N. Odor 156.1 ± 7.0,  
20.9 ± 0.9 
8 
G3 Anesthesia Alone 150.2 ± 2.5,  
20.1 ± 0.3 
9 
   Total = 25 
 
One week after arrival, animals received one day of handling, then were given a saline injection 
(0.3 ml, i.p.) once a day for the following three days.  Testing was performed the next day where 
animals were exposed to the odorants alone, anesthesia alone, or the odorants while anesthetized.  
Rats were sacrificed 12 hours after their respective treatments, a time point shown to correspond 
to stimulus-induced changes in PSA-NCAM (Foley et al., 2003).  Exposure to the odorant 
mixture was performed using a clean, empty rat cage in a hard-ducted hood similar to that 
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described in experiment ‘F’ for anesthetized animals.  For awake animals, two tubes of the 
undiluted odorant mixture were placed in the empty cage, and the rat was allowed to freely 
interact with the tubes for the duration of the 20 minute odorant exposure period.  The odorant 
mixture used was an equal mixture of 6 individual odorants (obtained from Sigma, St. Louis, 
MO):  isoamyl acetate, cineole, octanol, decanal, capronaldehyde, and R-(-)-carvone.  Animals 
were anesthetized with ketamine/xylazine anesthesia over an approximate 30 minute period with 
an average dose of 153.0 ± 3.5 and 20.5 ± 0.5 mg/kg, respectively.  There were no significant 
differences for anesthetic dose between groups (p = 0.42; student’s t-test; Table 4-4).  Lamps and 
heating pads were utilized to warm the animal as described in experiment ‘A’; however, direct 
measure of body temperature was not assessed. 
4.2.6 Experiment H:  Neurogenesis 
Table 4-5.  Group Layout:  Experiment 'H' 
Group Condition 
 
Cumulative Anesthetic Dose 
(mg/kg Ketamine, Medetomidine ± S.E.)  
Day: 20 / 21 / 22 
n = 
H1 Odor Only n/a 
 
n/a n/a 3 
H2 Air Only n/a 
 
n/a n/a 6 
H3 Odor and Anes 94.1 ± 19.0, 
0.63 ± 0.13 
85.8 ± 10.7, 
0.57 ± 0.07 
74.9 ± 0.08, 
0.50 ± 0.001 
7 
H4 Air and Anes 98.2 ± 15.4, 
0.65 ± 0.10 
 
75.0 ± 0.03, 
0.50 ± 0.00 
87.5 ± 7.7, 
0.58 ± 0.05 
5 
     Total = 21 
 
Upon arrival, rats received two consecutive days of BrdU (5-bromo-2'-deoxyuridine, Sigma, St. 
Louis, MO; Days 1 and 2) intraperitoneal injections (50 mg/kg dissolved in sterile saline).  On 
days 20, 21 and 22, rats received their respective conditions (Table 4-5) for two hours each day.  
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Rats either remained awake or were anesthetized with ketamine (Ketaset, Fort Dodge, Fort 
Dodge, IA) and medetomidine (domitor; Pfizer, New York, NY) anesthesia prior to treatment.  
Anesthetized animals were given an initial dose of 75mg/kg ketamine and 0.5mg/kg 
medetomidine.  Additional booster doses were administered as needed.  Cumulative anesthetic 
for each group is shown in table 4-4.  There were no significant differences in the average 
anesthetic dose between groups (p = 0.84; student’s t-test).  
Animals were placed in an empty rat cage within a hard-ducted hood for administration 
of respective treatments.  Air was pumped (1L/min) through a flask and into the sealed, empty 
cage.  The 125ml flask containing either 50ml of a banana scent (isoamyl acetate, Sigma) or a 
control, non-odiferous medium (mineral oil, Sigma) and was placed in a water bath at 25°C.   
Animals exposed to scent received 10 minutes of the odorant, then 10 minutes of air, alternating, 
throughout the 2 hour exposure period.  Animals in the ‘Air’ condition received air passed over 
mineral oil for the 2 hour duration.  Animals received three consecutive days of their respective 
treatments and were sacrificed on day 40. 
4.2.7 Immunohistochemistry 
At the designated time on the testing day animals were sacrificed and perfused with a solution of 
4% paraformaldehyde in phosphate buffered saline (PBS; pH 7.0).  Brains were post-fixed 
overnight and cryoprotected in a 30% sucrose/PBS solution with 0.01% sodium azide as a 
preservative.  30µm sections were generated for fluorescent microscopy using a sliding 
microtome (Leica, Buffalo Grove, IL) equipped with a freezing stage (Physitemp Instruments, 
Clifton, NJ).  Sections were blocked with 10% donkey blocking buffer (PBS with 10% donkey 
serum and 0.2% Triton X-100) for 2 hours at room temperature.  Primary antibodies against c-
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Fos (Calbiochem-EMD Biosciences, San Diego, CA; 1:5000), PSA-NCAM (Chemicon-
Millipore, Billerica, MA) and/or BrdU (GE Healthcare, Piscataway, NJ) were diluted in donkey 
blocking buffer and incubated with free-floating sections overnight at 4ºC.  Sections were then 
washed with PBS and incubated with Alexa Fluor 594 and/or 488-conjugated secondary 
antibodies (Invitrogen, Carlsbad, CA; 1:500) in the dark.  Sections were co-stained with the 
nuclear marker DAPI (4',6-diamidino-2-phenylindole; Sigma), washed and mounted onto slides 
using fluoromount-G mounting medium (SouthernBiotech, Birmingham, AL). 
Brains for BrdU immunohistochemistry (Experiment ‘H’) were fixed in 10% formalin 
(Fisher Scientific, Hampton, NH), but embedded in paraffin wax with the help of the core 
histology facility.  6µm sections were generated by a rotary microtome (American Optical Co., 
Buffalo, NY) placed in a warm water bath and mounted onto slides.  Paraffin sections were 
prepared for antibody staining by first exposing the slides to a series of hydrating washes 
(xylene-ethanol-water) followed by PBS.  Antigen retrieval was next performed by microwaving 
the sections in a 10mM sodium citrate solution for 12 minutes.  Sections were then processed for 
fluorescent immunohistochemistry as described above. 
4.2.8 Quantification 
Staining was imaged using an Olympus IX-81 widefield microscope equipped with a 
monochrome ORCA-ER (Hamamatsu, Bridgewater, NJ) peltier-cooled CCD camera.  Images 
were acquired and analyzed using QED - In Vivo and Image-Pro Plus (Media Cybernetics, 
Bethesda, MD) software.  Fluorescent images for experiments ‘E’ and ‘F’ were acquired under 
identical settings and uniformly quantified by a threshold method.  They were additionally 
screened by a set size and subjected to a watershed split function.  Comparisons were drawn only 
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between sections stained and imaged in the same session.  Sections for fluorescent c-Fos imaging 
were taken from +3.5mm, +3.3mm and +3.1mm rostrocaudal bregma in the cortex and +6.8mm 
and +7.9 rostrocaudal bregma in the olfactory bulb.  Fluorescent images for experiments ‘G’ 
(PSA-NCAM) and ‘H’ (BrdU) were also acquired under identical settings, but were quantified 
manually by blinded observers.  PSA-NCAM-labeled sections were taken from +3.3mm and 
+3.1mm rostrocaudal bregma in the cortex.  BrdU-labeled sections were taken from 
approximately +7.4mm rostrocaudal bregma in the olfactory bulb.  Labeling in fluorescent tissue 
was represented as positive cell number per mm2.    
4.2.9 Statistical Analysis 
One-way ANOVA was used to determine a significant overall difference followed by Tukey’s 
post hoc analysis for inter-group comparison.  A student’s t-test was utilized for experiments 
containing only two groups.  Values are described as group means ± standard error. For all analyses, 
differences were considered significant when p < 0.05. 
4.3 RESULTS 
4.3.1 Absence of consolidation during pentobarbital or propofol anesthesia 
We screened a number of injectible anesthetics to find the drug with the lowest degree of 
anesthetic-induced c-Fos activation (Fig. 4-1).  Based on our anesthetic screen, we investigated 
the effects of pentobarbital as this anesthetic produced little c-Fos immunoreactivity in the 
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olfactory bulb.  This allowed us to address the lack of an effect found in the olfactory bulb with 
ketamine/xylazine anesthesia.  In this previous experiment potential effects were obscured by 
high levels of anesthetic-induced c-Fos in this region (Fig. 2-7).  We could also assess whether 
the effects previously found in the APC and OFC (Fig. 2-5, 2-6) applied to other anesthetic 
types.   
 
Figure 4-1.  Expression of c-Fos in the olfactory bulb with various anesthetics 
Representative fluorescent micrographs of c-Fos immunolabeling in the granule and mitral cell layers of the 
olfactory bulb.  Data from anesthesia screen preliminary experiment.  Scale bar = 100µm. 
 
 
We anesthetized rats with pentobarbital (experiment ‘E’) and delivered either a novel 
odorant mixture (Pento & N. Odor; group E1) or no odorant mixture (Pento Alone; E2).  These 
two groups were compared and c-Fos expression was quantified in the OB(GCL), APC and OFC 
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(Fig. 4-2).  Student t-tests revealed no significant differences between Pento & N. Odor (E1) and 
Pento Alone (E2) groups in any region, unlike that observed with ketamine/xylazine anesthesia.   
We next investigated whether propofol anesthesia would allow odorant-induced changes 
in c-Fos similar to ketamine/xylazine (experiment ‘F’).  Comparison of animals anesthetized 
with propofol, then given a novel odorant mixture (Propofol & N. Odor; group F1) or 
anesthetized with no odorant mixture (Propofol Alone; F2) revealed no significant differences 
between these two groups in any of the regions assessed (student t-test).  It is important to note 
that in our original experiment (experiment ‘A’) naïve animals demonstrated very low baseline 
levels of c-Fos expression, unlike that seen in our pentobarbital or propofol alone groups, 
suggesting that high levels of anesthetic-induced c-Fos may be obscuring potential effects in 
these groups.  Though these data do not indicate an effect with propofol or pentobarbital, we 
cannot rule out potential effects with these anesthetics. 
 
Figure 4-2.  Effects of pentobarbital anesthesia on odor-induced c-Fos expression 
Quantification of c-Fos immunolabeling in the granule cell layer of the olfactory bulb (A), in the anterior piriform 
cortex (B) and in the orbitofrontal cortex (C).  Data from experiment ‘E’.   
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 Figure 4-3.  Effects of propofol anesthesia on odor-induced c-Fos expression 
Analysis of c-Fos protein expression in the granule cell layer of the olfactory bulb (A), in the anterior piriform 
cortex (B) and in the orbitofrontal cortex (C).  Data from experiment ‘F’.   
 
 
4.3.2 Cortical PSA-NCAM expression is unaffected by odorants and anesthesia 
Consolidation of associative odor memories has been shown to involve transient upregulation of 
PSA-NCAM in the hippocampus at twelve hours after the memory event (Foley et al., 2003).  
We wanted to test whether NCAM polysialylation occurred for simple odor recognition 
memories in the APC and OFC, and what effect anesthesia might have on this process.  Thus, we 
wanted to determine whether other forms of histological consolidation could occur under 
ketamine/xylazine anesthesia that complement our c-Fos data (Fig. 2-5, 2-6).  Rats were treated 
with scent and/or anesthesia similar to that in experiment ‘A’, however rats were sacrificed 
twelve hours after their respective treatments to assess PSA-NCAM expression (experiment ‘G’).  
We compared rats that received a novel odorant mixture (group G1), with rats that were given 
 103 
anesthesia and a novel odorant mixture (G2) or anesthesia alone (G3).  Naïve animals (A9) were 
also used as a negative control.  PSA-NCAM-positive cells were found in both regions for all 
groups; however, the density of cells was very sparse.  One-way ANOVA of the four groups 
(Fig. 4-4) revealed no significant differences in the APC (F(3,29) = 0.46; p = 0.71) or the OFC 
(F(3,29) = 1.86; p = 0.16).  These data suggest that NCAM polysialylation in the APC and OFC is 
not affected by simple odor recognition memory at 12 hours following odorant presentation.  




Figure 4-4.  Absence of PSA-NCAM effects in the APC and OFC 
PSA-NCAM immunolabeling (cells per mm2) in the anterior piriform cortex (A) and orbitofrontal cortex (B).  Data 




4.3.3 Effects of odor and anesthesia on neurogenesis 
To determine if the proliferation of adult neurogenesis was affected by administration of the 
odorant mixture in the presence or absence of ketamine/xylazine anesthesia, we analyzed the 
density of PSA-NCAM positive cells within the rostral migratory stream in experiment ‘G’ (Fig. 
4-5).  Naïve animals (group A9) were compared to animals that had received either a novel 
odorant mixture alone (G1), anesthesia and a novel odorant mixture (G2) or anesthesia alone 
(G3), twelve hours prior to sacrifice (Fig. 4-5).  One-way ANOVA revealed a significant effect 
of PSA-NCAM density for the section average (F(3,29) = 8.43; p < 0.001). Pair-wise comparison 
(tukey test; Fig. 4-5A) of the section average revealed a significant difference between 
Anesthesia & N. Odor (G2) and Anesthesia Alone groups (G3; p < 0.05) as well as between 
Anesthesia & N. Odor (G2) and Naïve groups (A9; p < 0.001).  Furthermore, a near-significant 
trend was found between Novel Odor (G1) and Naïve (A9) groups (p = 0.06; tukey posttest). 
It is reported that most neuroblasts migrate along the RMS at a rate of approximately 
100–120 µm/hr (Murase and Horwitz, 2002; Murase et al., 2008).  The speed of migration varies 
dramatically with a normally distributed migration rate ranging from 20-180 µm/hr (Murase et 
al., 2008).  It is possible that our 20 minute potent odorant exposure paradigm produced a 
transient bolus of migratory neuroblasts.  While it is difficult to determine the exact location of 
such a migratory bolus, the brain region sampled (+3.1mm and +3.3mm rostrocaudal bregma) is 
appropriate to see effects at 12 hours post-treatment.  As a migratory bolus may produce 
different effects along the rostrocaudal axis, we also report individual section densities. 
For the individual section +3.3mm bregma (Fig. 4-5B) we found a significant group 
effect (F(3,29) = 6.66; p < 0.01; one-way ANOVA).  Significant pair-wise effects were found 
between Novel Odor (G1) and Naïve (A9; p < 0.05) as well as Anesthesia & N. Odor (G2) and 
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Naïve (A9; p < 0.01) groups.  A near-significant trend was also found between Anesthesia & N. 
Odor (G2) and Anesthesia Alone groups in this region (p = 0.057; tukey posttest).   
At section +3.1mm bregma (Fig. 4-5C), a significant group effect was also found (F(3,29) 
= 4.53; p < 0.05; one-way ANOVA).  Post-hoc comparison revealed that Anesthesia & N. Odor 
(G2) and Naïve (A9) groups were significantly different (p < 0.01); however, there were no other 
significant effects.  The Anesthesia & N. Odor group (G2) was not significantly different than 
the Anesthesia Alone group (G3) in this section; however, a trend was again found (p = 0.06).  
Taken together, these data suggest that a novel odorant mixture induces enhanced neuroblast 
proliferation and migration in the presence or absence of anesthesia.  The presence of both the 
odorant mixture and anesthesia appeared to produce the most robust effect, suggesting that 
ketamine/xylazine anesthesia, itself, enhanced proliferation.  Indeed, ketamine has been reported 
to enhance neurogenesis (Keilhoff et al., 2004) and be neuroprotective (Hudetz and Pagel, 2010).  
Most importantly, however, the pattern of consolidation as indicated by proliferation between 
Anesthesia & N. Odor (G2) and Anesthesia Alone (G3) groups mimics that found for c-Fos 
consolidation in previous experiments (Fig. 4-5A vs Fig. 2-5 and 2-6). 
In another study (experiment ‘H’) we investigated the survival of adult newborn neurons 
following odorant exposure with and without simultaneous anesthesia.  We analyzed the number 
of BrdU-labeled cells residing within the olfactory bulb 20 days after odorant and/or anesthesia 
treatment (40 days after initial BrdU injection; Fig. 4-6).  Comparison of animals treated with 
Odor Alone (group H1), Air Alone (H2), Odor & Anes (H3) and Air & Anes (H4) revealed no 
significant group effects (One-way ANOVA; F(3,17) = 0.12; p = 0.95).  This suggests that our 
method of olfactory stimulation was not sufficient to enhance the survival of newborn neurons 
within the olfactory bulb, thus no conclusions could be drawn for the effects of anesthesia.   
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Figure 4-5.  Odor-induced precursor proliferation in the RMS with and without anesthesia 
Representative fluorescent micrograph of PSA-NCAM immunolabeling (red) and DAPI nuclear stain (blue) in the 
rostral migratory stream (outlined in white; A).  Quantification of PSA-NCAM density for the section average (B) 
and for individual sections at +3.1 mm (C) and +3.3 mm (D) rostrocaudal bregma.  Data from experiment ‘G’.  (*) p 
< 0.05 relative to ‘Naïve’, (†) p < 0.05 relative to ‘Anesthesia Alone’, one-way ANOVA with Tukey post hoc test.  





 Figure 4-6.  No effect on newborn neuron survival with odorant and/or anesthesia exposure 
Effects of odorant exposure and anesthesia on BrdU-labeled neurons in the granule cell layer of the olfactory bulb.  




In our earlier experiments (‘A’ and ‘B’), we found changes in c-Fos expression during and after 
ketamine/xylazine anesthesia, which may have indicated some level of information 
consolidation.  We therefore wanted to assess whether this effect was common to all anesthetics.  
Based on our preliminary work, we anesthetized animals with pentobarbital and found no impact 
of subsequent odorant exposure on c-Fos histology.  Comparable results were found with the 
anesthetic propofol.  However, similar to that seen with ketamine/xylazine anesthesia in the 
olfactory bulb (Fig. 2-7), it is possible that anesthetic-induced c-Fos is obscuring potential effects 
with pentobarbital and propofol.  Thus, the extent of stimulus-induced c-Fos with various 
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anesthetics remains inconclusive.  Regardless of the anesthetic ubiquity, the observation of odor-
induced information registration with even a single anesthetic is a considerable finding. 
Most common anesthetics are thought to act through the potentiation of inhibitory 
transmembrane channels such as GABAA and glycine (Rudolph and Antkowiak, 2004).  
Ketamine, in contrast, has little effect on these inhibitory receptors, but is instead thought to act 
through the inhibition of NMDA, and to a lesser extent, nACh signaling (Harrison and 
Simmonds, 1985; Martin and Lodge, 1985; Carla and Moroni, 1992; Krasowski and Harrison, 
1999).  The unique mechanism of action for ketamine anesthesia may explain the unique 
permissive effects found with c-Fos-mediated consolidation during ketamine/xylazine anesthesia 
in our studies.  The gaseous anesthetics nitrous oxide and xenon also have powerful effects on 
the NMDA and nACh receptors with comparatively little effect on the GABAA and glycine 
receptors relative to other volatile anesthetics (Yamakura and Harris, 2000; Hirota, 2006; Franks, 
2008).  The mechanisms of these anesthetics involve a number of key similarities with that of 
ketamine; therefore, it is possible that follow-up studies with nitrous oxide or xenon may reveal a 
permissive effect with c-Fos consolidation similar to that of ketamine/xylazine.   
During the screening of anesthetics, it was observed that animals anesthetized with 
etomidate were still responsive to a sudden, loud acoustic stimulus (e.g. a hand clap) despite a 
very high dose of anesthesia.  Etomidate is a short acting anesthetic with a potent effect on 
GABAA receptor function (Yang and Uchida, 1996; Pistis et al., 1997).  The acoustic response 
occurred reproducibly despite all physiological signs indicating full anesthesia.  This effect was 
not found in pentobarbital, propofol or even ketamine/xylazine treated animals.  Based on the 
residual processing in these etomidate-anesthetized animals, changes in c-Fos might also occur 
with olfactory stimuli, similar to that seen with ketamine/xylazine.  We purposefully avoided the 
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use of volatile anesthetics in our current olfactory experiments due to associated odors and the 
necessary involvement of olfaction/respiration in drug administration, a clear confounding 
variable.  
In our current study we confirmed the presence of PSA-NCAM positive cells within the 
piriform and orbitofrontal cortices; however, simple odor recognition memory did not appear to 
produce any changes in the number of PSA-NCAM-expressing cells within these regions.  PSA-
NCAM is suspected to play an important role in the hippocampus as disruption of NCAM 
polysialylation attenuates induction of long-term potentiation (LTP) in hippocampal slices and 
produces spatial learning difficulties on the Morris water maze task (Becker et al., 1996; Muller 
et al., 1996), with similar results found in NCAM knockouts (Cremer et al., 1994; Muller et al., 
1996).  It has been shown that hippocampal-dependent spatial learning and memory abilities 
correlate to NCAM PSA levels (Sandi et al., 2004).  Indeed, the changes in PSA-NCAM 
expression found previously were located in the dentate gyrus of the hippocampus (Fox et al., 
1995; Foley et al., 2003), which is a region of adult neurogenesis (Gould, 2007).  Based on BrdU 
labeling, it is reported that these effects were not dependent on neurogenesis (Fox et al., 1995; 
Foley et al., 2008).  However, PSA-NCAM is expressed only in neural precursors and is down-
regulated once neurons mature (Encinas et al., 2006).  Though no effects were found with PSA-
NCAM in the APC or OFC, we did find changes in PSA-NCAM within the rostral migratory 
stream, a neurogenic region (Gould, 2007).  This suggests that neurogenesis, or a permissive 
neurogenic environment, may somehow be necessary for memory-related changes in PSA-
NCAM.  Alternatively, PSA-NCAM may, in fact, be involved in the memory processes within 
the piriform and orbitofrontal cortices; however, changes in these regions may occur on a 
different timescale relative to that which occurs in the hippocampus (12 hours post-training).  It 
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is also possible that changes in NCAM-polysialylation are only involved in hippocampal-
dependent memory processes.  Analysis of APC/OFC PSA-NCAM at various time-points 
following odorant exposure may help clarify this ambiguity. 
With respect to neurogenesis, we found effects in proliferation as evident by changes in 
PSA-NCAM positive cells within the rostral migratory stream; however, no effects were found 
in survival as evident by BrdU labeling within the olfactory bulb.  While much is known about 
the factors regulating neurogenesis (Lledo et al., 2006; Hagg, 2007), the mechanisms of odor-
induced neurogenesis are not well understood.  It can be assumed that changes in the brain are 
occurring due to an interaction of the brain and environment: an interaction that may be 
disrupted by general anesthesia.  However, greater proliferation found in regions of the rostral 
migratory stream following exposure to the odorant mixture during anesthesia suggests that these 
processes can still occur, much in the same way that c-Fos processes continue to operate during 
general anesthesia.  The subventricular zone (SVZ) is a centrally located brain region that lies 
away from the olfactory bulb, yet gives rise to adult born olfactory bulb interneurons (Lois and 
Alvarez-Buylla, 1994; Gould, 2007).  Lesions that detach the olfactory bulb from the forebrain 
reduce the proliferation rate in the SVZ (Jankovski et al., 1998), suggesting that information 
from the olfactory bulb is transmitted to the subventricular zone which is used to modulate 
proliferation rate.  The odor-induced proliferation found in our current study supports this idea.  
This coherent OB/SVZ inter-region communication appears to occur despite surgical doses of 
ketamine/xylazine anesthesia.  In combination with our c-Fos results, these data support the 
notion of residual inter-region communication and information registration during 
ketamine/xylazine anesthesia. 
 111 
Effects found with proliferation, but not survival, suggest that newborn neurons, 
produced as a result of odor enrichment, do not integrate into the olfactory bulb on arrival.  This 
is not surprising as the majority of neuroblasts arriving from the sub-ventricular zone eventually 
die off after reaching the olfactory bulb (Biebl et al., 2000; Winner et al., 2002).  [3H]thymidine 
labeling experiments in rodents reveal that approximately 50% of new OB granule cells die off 
after 45 days, and this number increases to 75% at 12 (Petreanu and Alvarez-Buylla, 2002) and 
90% at 21 months (Kaplan et al., 1985).  Petreanu and Alvarez-Buylla (2002) found that after 4 
consecutive daily [3H]thymidine treatments, a maximum of 2.2% of total granule cell neurons 
were labeled 15 days later and only 1.5% were labeled at 45 days.  Thus, a small transient 
change in neurogenesis resulting from brief odorant exposure may be visible in the RMS, a 
highly concentrated region of neural precursors; however, this small change could easily be 
diluted out in the vast olfactory bulb, especially when viewed on a protracted timescale. 
It has been previously shown that complex odor enrichment enhances olfactory bulb 
neurogenesis (Rosselli-Austin and Williams, 1990; Rochefort et al., 2002; Rochefort and Lledo, 
2005).  The authors found that enrichment enhanced interneuron survival, but not proliferation, 
the opposite of what was found in our current study.  The discrepancy may depend on the 
method of assessing proliferation and survival.  For proliferation, the authors exposed mice to 20 
days of odor enrichment then delivered a single BrdU injection and assessed labeling 4 hours 
later in the rostral and caudal regions of the subventricular zone and in the caudal RMS.  In 
contrast, we kept rats in a relatively odor deprived environment up until they received a potent 
20 minute complex odor stimulus, and then assessed the density of immature neurons 12 hours 
later within various regions of the RMS as determined by PSA-NCAM immunolabeling.  It is 
possible that our abrupt and potent change in the odor environment was a more effective means 
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of altering proliferation rate.  It should be noted that greater BrdU labeling was indeed found by 
the authors in the anterior subventricular zone and caudal RMS; however, this effect was not 
significant (Rochefort et al., 2002).  For newborn neuron survival, Rochefort et al. (2002) 
exposed the animals to forty consecutive days of various odorants for 24 hours a day, whereas 
our animals were only exposed to three days of a single odorant for 2 hours a day.  Insufficient 
cumulative odorant exposure may be an alternate explanation for the lack of effects on survival 
in our study. 
These data have shown that c-Fos related information consolidation may not occur for 
every anesthetic.  Furthermore, while the extent of information consolidation with 
ketamine/xylazine anesthesia remains unclear, we have shown that this finding is not unique to 





5.0  GENERAL DISCUSSION 
5.1 POSSIBLE INTERPRETATIONS 
We have found that some level of memory-related information consolidation occurs in various 
brain regions including higher cortical areas despite a surgical plane of ketamine/xylazine 
general anesthesia.  The odorant-induced activation of c-Fos does not indicate that consolidation 
occurred to completion, but merely that consolidation mechanisms were activated.  Our effects 
found in approach latency suggest that memory formation may still occur, albeit in subconscious 
pathways.  These data indicate a functional disconnect between receiving and perceiving 
information.  However, if storage is occurring, why is there no explicit memory of the event?  
While the obvious answer may be that complete storage is not actually occurring, there are a 
number of possibilities.  One possibility is that a fully intact memory is formed under general 
anesthesia, but the percept of the odor has changed.  For example, a ‘banana’ odorant received 
during anesthesia might be remembered as ‘grape’, and when presented with ‘banana’ during the 
recall test the odor does not correspond to the memory and is reported as novel.  This might 
explain the discrepancy between c-Fos immunoreactivity and behavioral reports (Fig. 2-8).  In 
this view, anesthesia would skew the conscious percept similar to light diffracting through water.  
The shift in perception for each stimulus would have to vary randomly otherwise anesthesia 
would simply produce something similar to a coherent negative image of our world.  Such a 
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deficit in stimulus sorting and categorization may be more likely to mediate the anesthetic-
induced unconsciousness for anesthetics such as ketamine that augment regional brain activity 
(Duncan et al., 1998; Langsjo et al., 2005). 
 It is also possible that conscious perception does not reflect the total information that 
resides in the brain.  This concept is certainly not new and is evident in anyone who cannot recall 
the date of a loved one’s birthday, or a particular piece of trivia that they typically can remember.  
With respect to general anesthesia, this would suggest that consolidation may take place, but 
functional recall is absent.  This view is supported by numerous clinical findings that have shown 
that information presented during general anesthesia is stored as evident by subconscious, 
implicit memory following anesthesia.  In one example, thirty patients were presented a story 
through headphones during surgical propofol/alfentanil/N2O anesthesia, then asked to read the 
same story later while awake.  These patients showed a significantly faster reading rate (by 
approximately 40ms per word) of the story presented during anesthesia relative to a new story, 
similar to that found in control, unanesthetized patients (Munte et al., 1999).  Despite some 
claims to the contrary (Munte et al., 2000; Kerssens et al., 2005), a large body of literature has 
revealed that implicit, but not explicit, memory can form during a wide range of general 
anesthetics (Bailey and Jones, 1997; Kiviniemi, 1997; Ghoneim et al., 1999; Lubke et al., 1999; 
Ghoneim et al., 2000; Iselin-Chaves et al., 2005). 
The possibility of subconscious information consolidation is also supported by the 
blindsight literature, where patients can accurately describe visual stimuli in the absence of a 
conscious percept (Weiskrantz, 1996; Cowey, 2010).  Similar to that found with anesthesia, fully 
amnestic patients are able to perform normally on measures of implicit memory even though 
conscious recall is lacking (Warrington and Weiskrantz, 1970; Brooks and Baddeley, 1976; 
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Squire et al., 1987).  These studies indicate that information is received and stored despite 
amnesia, and suggest that the absence of memory may be due to a failure of recall.  However, 
evidence of implicit memory does not necessarily indicate that explicit memory was stored as 
well.  
Another possible conclusion is that conscious (explicit) and unconscious (implicit) 
pathways occur as parallel and separate memory systems.  Thus, the anesthetized state may 
prevent consolidation in the explicit memory pathway, while still allowing implicit memory 
consolidation.  Preserved implicit memory in amnesic patients with temporal lobe damage has 
lead researchers to believe that different neural structures underlie explicit and implicit memory 
(Squire, 1992; Tranel et al., 1994; Voss and Paller, 2008), therefore activation of only a single 
pathway may be possible.  This conclusion assumes that information consolidation does not 
occur in explicit memory systems.  While the exact roles of the anterior piriform cortex and 
orbitofrontal cortex in explicit versus implicit memory are not well understood, the c-Fos 
immunolabeling observed in these regions under anesthesia could indicate that we are actually 
observing mechanisms of implicit memory consolidation.  This would be consistent with the 
implicit memory effects found in our study and in the aforementioned clinical work.   
Alternatively, it is possible that our c-Fos labeling does in fact represent consolidation of 
explicit memory; however, these processes may have been incomplete or fragmented thus 
preventing explicit memory recall.  Expression of c-Fos is involved in a large cascade of cellular 
events and anesthesia may have an effect on downstream proteins in this cellular cascade, thus 
preventing the actions of c-Fos without any observable effect on c-Fos expression itself.  As 
anesthetics can differentially affect various brain regions, it is also possible that quasi normal 
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consolidation occurred in the APC and OFC; however, the encoding of a retrievable memory 
required additional regions that were not functioning properly during anesthesia.   
Indeed, it is likely that countless molecular events need to occur in numerous coordinated 
brain regions for an explicit memory to be fully consolidated and recallable.  Furthermore, it is 
plausible that even a slight disruption in any of these components might preclude robust 
consolidation.  Focal lesions to various cortical, limbic and thalamic sites all produce some 
disruption of olfactory memory (Staubli et al., 1984; Staubli et al., 1986; Staubli et al., 1987a; 
Slotnick and Risser, 1990; Staubli et al., 1995; Bunsey and Eichenbaum, 1996; Tait and Brown, 
2007).  Also mechanistically different neural insults, ranging from electroconvulsive shock and 
hypothermia, to ethanol and anticholinergics, all impair memory (Devietti and Hopfer, 1974; 
Jensen et al., 1975; Carballo-Marquez et al., 2007; Spinetta et al., 2008).  This indeed 
demonstrates that diverse mechanisms in numerous regions contribute to normal memory 
consolidation.  Thus, the mere activation of certain memory-related proteins provides little 
evidence of whether or not an explicit memory was formed.  Nevertheless, the finding that event-
specific registration can still occur, despite a behaviorally unconscious state, indicates a profound 
discovery.   
5.2 CURRENT VIEWS 
It has been proposed that immediate early genes, nicknamed “memory proteins”, are essential for 
the formation of long-term memories and that the amnestic effects of anesthesia are mediated by 
the disruption of these genes, specifically at the hippocampus (Alkire and Guzowski, 2008).  
This is based on a study where amnestic doses of propofol anesthesia were shown to block 
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activity-regulated cytoskeletal (Arc) protein expression in the hippocampus of rats trained on an 
inhibitory avoidance task.  Manipulations that rescued Arc expression in this region also rescued 
the memory (Ren et al., 2008).  Sevoflurane and desflurane have also been reported to block 
hippocampal Arc expression (Alkire and Guzowski, 2008).  Recently, the work from another 
group suggests that the residual effects of ketamine on memory may be mediated by suppression 
of c-Fos protein in the hippocampus (Peng et al., 2011).   
Arc and c-Fos are induced by learning and display strikingly similar expression patterns 
in the hippocampus (Grimm et al., 1997; Guzowski et al., 2001; Matsuo et al., 2009; Clark et al., 
2011).  Knockout of the alpha-isoform of calcium/calmodulin-dependent protein kinase II 
(alpha-CaMKII) produces deficits in memory function and also eliminates the learning-induced 
activation of both hippocampal c-Fos and Arc expression (Matsuo et al., 2009).  Furthermore, 
intracranial injections of drugs that enhance or inhibit memory function produce elevated or 
attenuated Arc protein expression, respectively, in the dorsal hippocampus.  Injection of Arc 
antisense oligodeoxynucleotides into this region of the hippocampus prior to training produces 
memory impairments on an inhibitory avoidance task (McIntyre et al., 2005).  This same 
procedure has also been shown to impair the maintenance phase of long-term potentiation (LTP) 
and produce deficits in long-term memory for a spatial water-maze task (Guzowski et al., 2000).  
Similar behavioral effects were also seen with hippocampal c-fos knockdown (Grimm et al., 
1997).  These studies suggest that the disruption of immediate early genes, specifically c-Fos and 
Arc, in the hippocampus may underlie amnestic effects.   
In the olfactory system, c-fos and arc also show similar expression patterns.  Both genes 
are activated robustly by a novel odorant and show an attenuated expression profile with a 
familiar odorant (Montag-Sallaz and Buonviso, 2002).  However, consolidation of olfactory 
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memories does not require hippocampal c-Fos expression (Bunsey and Eichenbaum, 1996; 
Tronel and Sara, 2002; Roullet et al., 2005b).  Olfactory memory tasks appear to activate c-Fos 
in the hippocampus only if these tasks involve a spatial component, social cues or complex 
learning (Staubli et al., 1995; Countryman et al., 2005; Roullet et al., 2005a).  Spatial olfactory 
tasks produce elevated c-Fos immunoreactivity only in the CA1, and not the CA3 or dentate 
gyrus, after learning (Roullet et al., 2005a), which may result from the role of the hippocampus 
in spatial memory.  Olfactory memory tasks that do not involve spatial learning or social cues, 
produce little observable c-Fos immunoreactivity in the hippocampus (Tronel and Sara, 2002).   
It is possible that olfactory memories involve changes in Arc, but not c-Fos, expression in 
the hippocampus.  Despite their similar expression profiles, these genes have different functional 
roles.  c-Fos is a regulatory transcription factor (RTF) and influences neural function by its 
effects on downstream genes, whereas Arc is an ‘effector’ protein that directly affects cellular 
functions, specifically cytoskeletal proteins in a process that is thought to impact neural plasticity 
(Guzowski, 2002; Terleph and Tremere, 2006).  We were unable to find evidence of Arc protein 
expression in the olfactory bulb with several different antibodies (data not shown) at the time-
point used for c-Fos protein expression (2 hours after stimulus), but we did not assess Arc 
expression in higher cortical olfactory regions or in the hippocampus.  Given the similar ability 
of both genes to be induced by a variety of tasks in the hippocampus (Guzowski et al., 2001; 
Matsuo et al., 2009; Clark et al., 2011), it is unlikely that these genes would show an opposite 
pattern of expression for tasks involving olfactory memory.  It is therefore plausible that 
immediate early gene expression in other brain regions is involved in the anesthetic-induced 
amnesia for olfactory memory.  Such a conclusion is supported by lesion studies which have 
demonstrated that complete ablation of the hippocampus does not prevent the acquisition of odor 
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associations; although, more complex forms of learning such as odor transitivity and symmetry 
are impaired (Staubli et al., 1995; Bunsey and Eichenbaum, 1996).   
It should be noted that the olfactory system is unique in that it is the only modality that is 
not necessarily gated through the thalamus.  Olfactory processing involves direct connections to 
the orbitofrontal cortex from the pirifrorm cortex, and indirect connections that are sent through 
the thalamus (Shepherd, 2007).  In addition, there are fewer synaptic connections required for 
olfactory information to reach higher cortical areas, relative to other sensory systems.  
Thalamocortical projections may also not be necessary for the acquisition of olfactory memories 
(Staubli et al., 1987a).  This unique circuitry may explain the lack of c-Fos activation in the 
hippocampus (Tronel and Sara, 2002), and suggests the possibility that other loci more central to 
olfactory pathways may have co-opted this function.  One possible region is the anterior piriform 
cortex, as this area has been implicated to play a role in learning and memory (Barkai and Saar, 
2001; Sanchez-Andrade et al., 2005).   
It was found that intrahippocampal injection of a c-fos antisense oligonucleotide reduced 
gene expression within the hippocampus, but also in other limbic and cortical regions (Grimm et 
al., 1997), suggesting that the effects of knockdown on non-olfactory memories could have 
actually occurred at a location distal to the hippocampus.  In support of this, c-fos knockdown in 
regions outside the hippocampus has been shown to impair memory consolidation for 
conditioned fear, passive avoidance and taste aversion tasks (Lamprecht and Dudai, 1996; 
Mileusnic et al., 1996; Morrow et al., 1999; Yasoshima et al., 2006).  Thus, the hippocampus is 
not the only critical locus for IEG functions.  This is true for both olfactory and non-olfactory 
memory tasks. 
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Consistent with the views of Alkire and Guzowski (2008) and others (Ren et al., 2008), 
we have found that propofol and pentobarbital anesthesia appeared to eliminate learning-induced 
elevations in IEG expression, albeit in olfactory regions.  However, with ketamine/xylazine 
anesthesia we found that immediate early gene expression not only persisted, but showed 
changes similar to that which occurred in the awake state.  The easiest way to reconcile this 
finding is that our results were not in the hippocampus, and the hypothesis put forth by Alkire 
and Guzowski (2008) did not indicate any expectation of a global IEG effect.  Little is known 
about the effects of ketamine/xylazine anesthesia on Arc expression.  However, based on our 
findings, it is likely that ketamine/xylazine anesthesia would not prevent hippocampal Arc 
activation in memory tasks of another modality.  Such a finding would indeed be inconsistent 
with this model of IEG function and anesthetic-induced amnesia, and would force a re-evaluation 
of our understanding.  In the absence of requisite hippocampal function for simple olfactory 
memories, our finding of residual ‘memory protein’ expression, during anesthesia, in areas 
proposed to play a role in olfactory memory, already casts doubt on some of the underlying 
themes of Alkire and Guzowski’s hypothesis. 
In a recent review article in Science, Michael Alkire, Anthony Hudetz and Giulio Tononi 
concluded by saying: “Thus, anesthetics seem to cause unconsciousness when they block the 
brain’s ability to integrate information (Alkire et al., 2008).”  Though much depends on the 
definition of ‘integrate’ and ‘unconsciousness’, terms which are subject to a variety of 
interpretations, our data challenge the current understanding of anesthesia and memory processes 
and suggest that information integration and unconsciousness are not mutually exclusive.   
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5.3 WHY KETAMINE/XYLAZINE? 
We found evidence of information integration during ketamine/xylazine anesthesia as seen by 
changes in c-Fos protein expression in cortical olfactory regions and changes in PSA-NCAM in 
the rostral migratory stream.  These changes reflected those observed during the awake state.  
Despite these changes in protein expression, explicit memory recall was still absent in these 
animals.  However, it is possible that an implicit or autonomic memory still persisted.  So, why 
were we able to see these brain changes during ketamine/xylazine anesthesia and not with 
propofol or pentobarbital anesthesia?   
Ketamine belongs to the cyclohexamine class of drugs which are categorized as 
sympathomimetic anesthetics (Soma, 1983).  These drugs produce a cataleptic anesthetic state 
characterized by muscle rigidity and analgesic properties.  Ketamine also produces anesthesia, 
amnesia, changes in autonomic function (elevated heart rate, blood pressure and respiration; 
bronchodilation) and tremors and seizures at higher doses; however, this is significantly 
minimized by the co-administration of drugs such as xylazine or diazepam (Soma, 1983; Reich 
and Silvay, 1989; Haas and Harper, 1992).  Pharmacologically, ketamine is a non-competitive 
antagonist of the N-methyl-D-aspartate (NMDA) receptor, which mediates slow excitatory, 
glutamatergic neurotransmission (Martin and Lodge, 1985).  Ketamine also inhibits the nicotinic 
acetylcholine receptor (nAChR); however unlike most anesthetics, with the exception of xenon 
and perhaps nitrous oxide, ketamine is thought to have little or no effect on GABAergic 
receptors (Anis et al., 1983; Krasowski and Harrison, 1999).  At anesthetic doses ketamine also 
interacts with the µ opioid and sigma receptors, but to a lesser extent (Hirota et al., 1999; Narita 
et al., 2001).  Xylazine is a sedative that is commonly used in combination with ketamine or 
other anesthetics in veterinary medicine to produce sedation, muscle relaxation and analgesia at 
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higher doses (Soma, 1983).  Xylazine acts as an α2-adrenergic receptor agonist which is thought 
to modulate norepinephrine release (Kobinger, 1978; Greene and Thurmon, 1988).   The unique 
molecular targets of ketamine/xylazine anesthesia may help explain the effects found with this 
drug in our current experiments. 
The exact role of specific neurotransmitter systems in altering brain circuitry and 
mediating the phenotypes of various anesthetics is not well understood.  In the olfactory bulb, 
granule cells contribute to lateral inhibition through dendrodendritic and often reciprocal 
synapses with mitral/tufted cells, the principle neurons that mediate synaptic transmission to 
higher cortical regions (Mori et al., 1999; Urban and Arevian, 2009).  This process is thought to 
facilitate the production of a coherent odor representation.  Traditional GABAergic anesthetics 
enhance granule cell-mediated inhibition of mitral/tufted cells (Nicoll, 1972; Tsuno et al., 2008).  
In contrast, NMDA-antagonists, including ketamine, have been shown to reduce the granule cell 
mediated inhibition, thus enhancing mitral/tufted cell excitability (Wilson et al., 1996).  
Disinhibition of mitral/tufted cells and removal of granule cell-mediated lateral inhibition may 
produce a stronger, albeit incoherent, signal transmitted to the piriform cortex.  This signal might 
then produce robust c-Fos activation that is not associated with an entirely coherent odor 
representation.  Enhanced bulbar-piriform signaling with ketamine/xylazine anesthesia is 
supported by our raw c-Fos micrographs (Fig. 2-5 and 2-6) which reveal stronger (darker) c-Fos 
expression in individual neurons when an odorant mixture is presented during anesthesia, 
relative to when the odorant mixture is presented while awake.  Such an interpretation may 
explain the elevated c-Fos immunoreactivity observed specifically with ketamine/xylazine 
anesthesia in the absence of an olfactory memory.  Indeed, ketamine-mediated disinibition of 
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excitatory neurons is thought to underlie the activating effects of this drug in various brain 
regions (Brown et al., 2010). 
Ketamine is also categorized as a dissociative anesthetic, which produces a feeling of 
detachment from one’s surroundings.  These types of anesthetics involve sensory impairment 
and amnesia, but can also produce unwanted side-effects.  Some believe the actions of 
dissociatives, such as ketamine, occur without full loss of consciousness (Winters et al., 1972; 
Bonta, 2004).  One major issue with the administration of ketamine anesthesia in humans is the 
prevalence of ‘emergence phenomena’ which includes distressing hallucinations, vivid dreams, 
floating sensations and delirium.  This occurs in 3% to 30% of patients; however, co-
administration with sedatives reduces these experiences (Reich and Silvay, 1989; Strayer and 
Nelson, 2008).  The hallucinatory properties of subanesthetic ketamine have lead to the increased 
illicit use of this agent as a recreational drug (Degenhardt et al., 2005).  The drug is also thought 
to produce schizophrenia-like symptoms and has been used as a model to study the disorder 
(Northoff et al., 2005; Bubenikova-Valesova et al., 2008).   
Similar to other anesthetics, ketamine produces anterograde amnesia at subanesthetic 
doses and retrograde amnesia at higher doses (Pitsikas et al., 2008; Boultadakis and Pitsikas, 
2011).  Ketamine has a greater amnestic effect on males than on females (Morgan et al., 2006); 
however, females are more likely to experience emergence phenomena than males (Craven, 
2007), a finding that may result from the differential effect of sex hormones on the NMDA 
receptor (Morgan et al., 2006). 
As opposed to the central nervous system depression produced by most other anesthetics, 
ketamine produces a global activation as assessed by PET cerebral blood flow in humans 
(Langsjo et al., 2003; Langsjo et al., 2005), and BOLD fMRI (Littlewood et al., 2006), 2-DG and 
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c-Fos labeling in rodents (Duncan et al., 1998).  Most anesthetics also cause an EEG state similar 
to deep sleep; however, ketamine produces more of an active EEG state (Schuttler et al., 1987; 
Maksimow et al., 2006; Tsuda et al., 2007; Franks, 2008).  The active brain state associated with 
ketamine is thought to be produced by the inhibition of excitatory NMDA receptors on inhibitory 
interneurons.  Ketamine specifically inhibits cortical, hippocampal and limbic interneurons, thus 
disinhibiting glutamatergic pyramidal neurons.  This produces an uncoordinated active state 
thought to mediate unconsciousness (Olney et al., 1999; Seamans, 2008; Brown et al., 2010).  
BOLD fMRI studies in rodents revealed that administration of a nociceptive stimulus to rats fully 
anesthetized with ketamine anesthesia produced activation in the sensory-motor cortex, insular 
cortex, cingulate cortex and other regions associated with pain processing (Shih et al., 2008).  An 
fMRI study in monkeys administered low dose ketamine demonstrated that the brains of these 
animals not only received visual stimuli, but were able to use the information to drive a 
sensorimotor loop despite behavioral dissociation (Leopold et al., 2002).  Based on these studies, 
residual cognitive processes active during ketamine/xylazine anesthesia may allow changes in 
gene expression, typically occurring in the awake state, to persist without fully integrating the 
information within the normal cognitive hierarchy, a process that likely requires conscious 
perception.   
The atypical molecular targets, elevated brain activity and residual processing unique to 
ketamine anesthesia provide several possible explanations for the c-Fos and PSA-NCAM-related 
information consolidation that appeared to occur during ketamine/xylazine, but not pentobarbital 
or propofol, anesthesia.   
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5.4 FUTURE DIRECTIONS 
We have demonstrated changes in immediate early gene function in the anterior piriform cortex 
and orbitofrontal cortex that reflect olfactory experiences and persist under ketamine/xylazine 
anesthesia.  Previous studies have demonstrated that immediate early gene expression in specific 
brain loci is required for certain types of memory formation (Guzowski et al., 2000; McIntyre et 
al., 2005).  Though we have found changes with c-Fos in olfactory cortical regions that are 
temporally linked to memory consolidation, the functional relevance of these changes in 
expression is still unknown.  One method to assess whether c-fos function is necessary for 
olfactory memory formation in the APC and OFC is to reduce or eliminate c-fos function in these 
regions.  Focal knockdown of c-fos has been shown to produce greater effects on learning and 
memory than global gene knockout, which can lead to upregulation of compensatory genetic 
mechanisms (Yasoshima et al., 2006).  Thus, focal knockdown of c-fos mRNA in the APC and 
OFC would be ideal to elucidate the role of c-fos in the particular stages of olfactory memory 
processing.  If c-fos expression in one or both regions is found to be required for olfactory 
memory consolidation, then follow-up studies would be necessary to determine why c-Fos 
expression could occur in these regions under ketamine/xylazine anesthesia without leaving an 
explicit memory trace.  Such studies could explore the function of downstream targets of c-Fos. 
Much is known about the regions of the brain activated by olfaction (Savic, 2002a, b).  
The cortical and subcortical regions required for the storage, maintenance and retrieval of 
olfactory memories as well as for olfactory discrimination, however, are not well understood.  
The areas active during odorant stimulation with ketamine/xylazine or other anesthetics are even 
less well known, but may provide some insight into the regions involved in conscious perception.  
Future studies could address IEG function in the following regions: 
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 Entorhinal Cortex – The entorhinal cortex has efferent and afferent connectivity with the 
hippocampus, and connects this region to other cortical areas (Witter, 1993).  Lesions to 
the entorhinal cortex can impair some forms of olfactory memory acqisition (Staubli et 
al., 1984; Staubli et al., 1986).  However, others claim that the entorhinal cortex is not 
necessary for olfactory memory (Slotnick and Risser, 1990).  Further studies found that 
entorhinal lesions allowed long-term olfactory memories to be made, but produced 
impairments in olfactory working memory (Staubli et al., 1995).   
 Perirhinal Cortex – In the rodent, the perirhinal cortex receives considerable inputs from 
olfactory areas, and has connections with the orbitofrontal cortex, entorhinal cortex and 
hippocampus among other regions (Suzuki, 1996).  This area has been shown to be 
required for familiarity-based recognition (Eichenbaum et al., 2007).  The perirhinal 
cortex was also shown to produce abundant c-Fos labeling in response to an olfactory 
memory task despite an absence of labeling in the hippocampus (Tronel and Sara, 2002). 
 Basolateral Amygdala – The basolateral amygdala is a limbic brain region thought to 
weigh incoming stimuli and memories with emotional saliency.  The BLA shows a 
dramatic elevation in c-fos following olfactory memory acquisition (Hess et al., 1997; 
Tronel and Sara, 2002).  Electrophysiological data shows that BLA neurons generate 
selective responses to odorants associated with reward (Schoenbaum et al., 1999).  
Additionally, the BLA has been suggested to be critical for anesthetic-induced amnesia as 
lesions to the BLA block propofol- (Alkire et al., 2001), sevoflurane- (Alkire and Nathan, 
2005) and diazepam- (Tomaz et al., 1992) induced amnesia. 
 Locus Coeruleus – Expression of c-fos shows rhythmic variations with significantly 
greater expression throughout the cortex during the waking (conscious) state.  This 
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 Hippocampus – The hippocampus has been proposed to play a role in olfaction as this 
region is uniquely responsive to olfactory stimuli, over that of other modalities 
(Vanderwolf, 2001).  Furthermore, odorant presentation can produce synchronous 
rhythms between the hippocampus, olfactory bulb and cortex (Macrides et al., 1982).  
Lesions which disrupt hippocampal function impair the formation of complex olfactory 
memories, but do not affect simple memory acquisition (Staubli et al., 1984; Staubli et 
al., 1995; Bunsey and Eichenbaum, 1996).  Though olfactory associations do not cause 
robust c-Fos activation in this region (Tronel and Sara, 2002), it is possible that Arc may 
instead be activated, or that this region is involved in olfactory memory formation 
through IEG-independent mechanisms.  Though c-Fos protein was not upregulated by 
non-spatial olfactory tasks, c-fos mRNA can be upregulated (Hess et al., 1995a, b).  A 
similar discrepancy between mRNA and protein expression has been demonstrated in the 
hippocampus with the IEG, Arc (Ren et al., 2008).   
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 Dorsomedial Thalamic Nucleus (DMN) – The dorsomedial thalamic nucleus is the region 
of the thalamus that is involved in olfactory processing (Staubli et al., 1987a).  Lesions to 
this region impair the ability of rats to learn new odor discriminations, however extensive 
training can offset this deficit (Staubli et al., 1987a; Slotnick and Risser, 1990). 
 Other Regions – The prelimbic cortex and the habenula both have been shown to produce 
preferential c-Fos expression when an odor and reward are paired (Tronel and Sara, 
2002), indicating a potential role in olfactory memory.  The midbrain reticular formation 
is a region of interest as it is involved in sleep and arousal and is thought to be a target of 
general anesthetics (Alkire et al., 2000; Rudolph and Antkowiak, 2004).  Finally, the 
olfactory tubercle and the anterior olfactory nucleus are also plausible candidates as these 
regions receive direct olfactory input from the bulb (Shepherd, 2007), however their 
functions are not well understood. 
 
The NMDA receptor is also an interesting candidate for future study.  This receptor is a 
voltage and ligand gated ionotropic glutamate receptor that has long been implicated to play an 
important part in learning and memory due to its role in mediating LTP (Collingridge et al., 
1983).  NMDA-antagonists, AP5 and MK-801, have been shown to impair memory of odor-
reward, passive avoidance, Morris water maze and radial maze tasks (Morris et al., 1986; Danysz 
et al., 1988; Caramanos and Shapiro, 1994; Tronel and Sara, 2003).  Inhibition of NMDA 
function was most effective when administered between 5 and 90 minutes post-training 
(Przybyslawski and Sara, 1997).  It has been shown that an odor-reward association task 
produces a significant reduction in NMDA receptor density in the frontal cortex and 
hippocampus at 30 minutes post-training (Roullet et al., 1999).  Also, several groups have shown 
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a relationship between NMDA receptor density and retention (Wenk et al., 1989; Keller et al., 
1992; Stecher et al., 1997).  While it is known that some anesthetics (e.g. ketamine) have direct 
effects on NMDA receptor function, the role of anesthesia in modulating NMDA receptor 
density with regard to olfactory or other memory types has not been adequately investigated. 
 
5.5 SIGNIFICANCE 
Clinically, one of the concerns in the field of anesthesiology is the rare occurrence of anesthesia 
awareness, which involves both consciousness during anesthesia and the ability to recall the 
memory (Goldmann, 1988).  Indeed, there are numerous clinical reports of explicit memory 
formation under general anesthesia (Ghoneim and Block, 1992; Ghoneim, 2000; Sebel et al., 
2004; Errando et al., 2008), especially when the information is emotionally salient (Trustman et 
al., 1977).  Recent large-scale clinical studies have revealed an incident rate of recall following 
anesthesia to range from 0.1% to 1.0% (Sandin et al., 2000; Sebel et al., 2004; Errando et al., 
2008; Malviya et al., 2009; Xu et al., 2009) with some estimates as high as 4% or greater 
(Weinberger et al., 1984).  While the existence of implicit memory formation during surgical 
anesthesia is generally accepted (Block et al., 1988; Bailey and Jones, 1997; Kiviniemi, 1997), 
explicit memory formation is typically regarded as an epiphenomenon of clinical errors.  Indeed, 
most controlled studies have not found evidence of explicit memory (Ghoneim et al., 1999; 
Lubke et al., 1999; Iselin-Chaves et al., 2005); however, there have been exceptions (Russell and 
Wang, 1997; Ghoneim et al., 2000).  Those who claim to experience anesthesia awareness report 
pronounced anxiety during the surgical procedure.  In one study, patients who experience 
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awareness during anesthesia were interviewed 2 years after the incident and most reported 
moderate to severely debilitating psychological issues that had persisted from the time of the 
event (Lennmarken et al., 2002).  It is estimated that 26,000 new cases of anesthesia awareness 
occur in the United States each year (Sebel et al., 2004).  Given the prevalence of this issue, the 
profound psychological and medicolegal repercussions, and the possibility to influence 
postoperative progress (Ghoneim and Block, 1992), a greater understanding of the cognitive 
processes during anesthesia is warranted.  These reports reveal that our ability to gauge 
consciousness is still quite limited (Alkire et al., 2008).   
 Admittedly, our studies in rodents have not brought us much closer to reducing the 
prevalence of awareness during clinical anesthesia.  However, we have continued to expand the 
idea of what the anesthetized brain is capable of.  We have demonstrated a profound result that 
the molecular pathways of memory are activated despite an unconscious state.  Continued study 
of immediate early gene function in the awake and anesthetized state may help elucidate the 
various brain regions necessary for anesthetic-induced unconsciousness.  These data might 
eventually help anesthesiologists improve patient treatments and reduce anesthesia-related 
sequela.  More importantly, however, the recent work in immediate early gene function suggests 
that the molecular mechanisms of consciousness are starting to be unraveled.   
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APPENDIX A 
RECONCILIATION OF QUANTIFICATION TECHNIQUES 
This appendix includes the control and extended quantifications from chapter 2.  Figure A-1 
demonstrates robust behavioral effects regardless of scoring technique or timeframe assessed.  
Automated scoring included the net time the rodent’s snout spent within the 2” diameter odorant 
zone, independent of behavior (active smelling vs. stationary position).  Manually scored 
behavior was performed by blinded observers looking for only active smelling behaviors within 
the odorant zone.  The raw data from these graphs can be visualized through snout traces (Fig. 
A-2).  Snout traces indicate the path of the rodent’s snout from the first 100 seconds after 
approaching the odorant zone.   
 Figure A-3 demonstrates that data from figures 2-5 and 2-6 can be obtained with differing 
quantification techniques.  Original stereological data (Fig. A-3A) can be replicated with a 
software threshold quantification technique (Fig. A-3B), or through blinded manual counting 
(Fig. A-3C). 
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 Figure A-1.  Quantification of behavioral data with automated and manual scoring techniques 
Odor familiarity with the odorant was assessed by duration of odor investigation time.  (A) Odor investigation times 
as assessed by automated (A) and manual scoring (B).  Smelling duration was determined by the duration of time 
the snout was within the odorant zone within the first 10, 30 and 100 seconds after approach.  Data from experiment 




 Figure A-2.  Raw traces of the snout path 
Path images show the position of each rodent’s nose within the behavioral chamber during the test period.  Traces 




 Figure A-3.  Similar results of c-Fos quantification regardless of counting technique 
c-Fos immunolabeling in the anterior piriform cortex (APC) and orbitofrontal cortex (OFC) as determined by (A) 
stereology, (B) threshold and (C) manual counting techniques.  Data from experiment ‘A’.  (*) p < 0.05 relative to 
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